{
  "metadata": {
    "total_items": 269,
    "audit_date": "2026-02-06T18:39:36.479Z"
  },
  "summary": {
    "by_category": {
      "decision_support": 83,
      "background": 167,
      "policy": 16,
      "data_point": 3
    },
    "by_source_type": {
      "nccn": 56,
      "pubmed": 82,
      "payer-moldx-palmetto": 4,
      "payer-moldx-cgs": 2,
      "payer-moldx-noridian": 1,
      "payer-medicare-lcd": 2,
      "asco": 8,
      "esmo": 10,
      "sitc": 2,
      "fda": 3,
      "rss-esmo": 2,
      "rss-asco": 8,
      "seed_publication": 8,
      "guideline": 2,
      "regulatory": 1,
      "extracted_publication": 39,
      "clinicaltrials": 39
    },
    "by_cancer_type": {
      "bladder": 7,
      "breast": 17,
      "colorectal": 57,
      "melanoma": 3,
      "esophageal": 4,
      "gastric": 5,
      "head_neck": 6,
      "lung_nsclc": 30,
      "ovarian": 2,
      "pancreatic": 2,
      "multi_solid": 91,
      "lung_sclc": 4,
      "sarcoma": 2,
      "unspecified": 70,
      "merkel_cell": 3,
      "multiple_myeloma": 2,
      "all": 2,
      "cll": 1,
      "renal": 2
    },
    "by_evidence_type": {
      "guideline": 74,
      "RCT": 4,
      "review": 14,
      "prospective_cohort": 5,
      "observational": 64,
      "payer_policy": 4,
      "billing_guidance": 2,
      "billing_article": 3,
      "clinical_practice_guideline": 10,
      "consensus_statement": 2,
      "regulatory": 4,
      "rct_results": 59,
      "consensus": 4,
      "meta_analysis": 3,
      "retrospective_cohort": 2,
      "rct_ongoing": 15
    }
  },
  "gap_analysis": {
    "total_gaps": 0,
    "cancer_types": [
      "all",
      "bladder",
      "breast",
      "cll",
      "colorectal",
      "esophageal",
      "gastric",
      "head_neck",
      "lung_nsclc",
      "lung_sclc",
      "melanoma",
      "merkel_cell",
      "multi_solid",
      "multiple_myeloma",
      "ovarian",
      "pancreatic",
      "renal",
      "sarcoma",
      "unspecified"
    ],
    "decision_points": [
      "unclassified"
    ],
    "gaps": []
  },
  "null_decision_context": {
    "count": 89,
    "items": [
      {
        "id": 1,
        "title": "NCCN Bladder Cancer: post-cystectomy surveillance",
        "evidence_type": "guideline",
        "category": "decision_support"
      },
      {
        "id": 2,
        "title": "NCCN Bladder Cancer: advanced/metastatic disease monitoring",
        "evidence_type": "guideline",
        "category": "decision_support"
      },
      {
        "id": 3,
        "title": "NCCN Bladder Cancer: advanced disease treatment decisions",
        "evidence_type": "guideline",
        "category": "decision_support"
      },
      {
        "id": 4,
        "title": "NCCN Breast Cancer: metastatic disease progression on endocrine therapy",
        "evidence_type": "guideline",
        "category": "decision_support"
      },
      {
        "id": 5,
        "title": "NCCN Breast Cancer: metastatic disease when ctDNA shows ESR1 negative with low tumor fraction",
        "evidence_type": "guideline",
        "category": "decision_support"
      },
      {
        "id": 6,
        "title": "NCCN Breast Cancer: metastatic disease biomarker testing",
        "evidence_type": "guideline",
        "category": "decision_support"
      },
      {
        "id": 7,
        "title": "NCCN Breast Cancer: ctDNA testing interpretation",
        "evidence_type": "guideline",
        "category": "decision_support"
      },
      {
        "id": 8,
        "title": "NCCN Breast Cancer: ctDNA testing with low tumor fraction",
        "evidence_type": "guideline",
        "category": "decision_support"
      },
      {
        "id": 9,
        "title": "NCCN Colorectal Cancer: surveillance",
        "evidence_type": "guideline",
        "category": "decision_support"
      },
      {
        "id": 10,
        "title": "NCCN Colorectal Cancer: adjuvant therapy and surveillance",
        "evidence_type": "guideline",
        "category": "decision_support"
      },
      {
        "id": 11,
        "title": "NCCN Colorectal Cancer: adjuvant therapy and surveillance",
        "evidence_type": "guideline",
        "category": "decision_support"
      },
      {
        "id": 12,
        "title": "NCCN Colorectal Cancer: adjuvant therapy",
        "evidence_type": "guideline",
        "category": "decision_support"
      },
      {
        "id": 13,
        "title": "NCCN Melanoma Cancer: molecular testing for targetable mutations",
        "evidence_type": "guideline",
        "category": "decision_support"
      },
      {
        "id": 14,
        "title": "NCCN Melanoma Cancer: molecular testing when liquid biopsy is negative",
        "evidence_type": "guideline",
        "category": "decision_support"
      },
      {
        "id": 15,
        "title": "NCCN Esophageal Cancer: metastatic or advanced disease",
        "evidence_type": "guideline",
        "category": "decision_support"
      },
      {
        "id": 16,
        "title": "NCCN Esophageal Cancer: surveillance/monitoring",
        "evidence_type": "guideline",
        "category": "decision_support"
      },
      {
        "id": 17,
        "title": "NCCN Esophageal Cancer: general interpretation",
        "evidence_type": "guideline",
        "category": "decision_support"
      },
      {
        "id": 18,
        "title": "NCCN Gastric Cancer: metastatic or advanced gastric cancer",
        "evidence_type": "guideline",
        "category": "decision_support"
      },
      {
        "id": 19,
        "title": "NCCN Gastric Cancer: preoperative therapy monitoring",
        "evidence_type": "guideline",
        "category": "decision_support"
      },
      {
        "id": 20,
        "title": "NCCN Head_neck Cancer: nasopharyngeal carcinoma management",
        "evidence_type": "guideline",
        "category": "decision_support"
      },
      {
        "id": 21,
        "title": "NCCN Head_neck Cancer: post-treatment surveillance",
        "evidence_type": "guideline",
        "category": "decision_support"
      },
      {
        "id": 22,
        "title": "NCCN Head_neck Cancer: induction chemotherapy monitoring",
        "evidence_type": "guideline",
        "category": "decision_support"
      },
      {
        "id": 23,
        "title": "NCCN Head_neck Cancer: advanced nasopharyngeal carcinoma",
        "evidence_type": "guideline",
        "category": "decision_support"
      },
      {
        "id": 24,
        "title": "NCCN Lung_nsclc Cancer: general testing principles",
        "evidence_type": "guideline",
        "category": "decision_support"
      },
      {
        "id": 25,
        "title": "NCCN Lung_nsclc Cancer: early stage disease",
        "evidence_type": "guideline",
        "category": "decision_support"
      },
      {
        "id": 26,
        "title": "NCCN Lung_nsclc Cancer: thoracic metastatic disease",
        "evidence_type": "guideline",
        "category": "decision_support"
      },
      {
        "id": 27,
        "title": "NCCN Lung_nsclc Cancer: advanced/metastatic disease",
        "evidence_type": "guideline",
        "category": "decision_support"
      },
      {
        "id": 28,
        "title": "NCCN Lung_nsclc Cancer: progression on targeted therapy",
        "evidence_type": "guideline",
        "category": "decision_support"
      },
      {
        "id": 29,
        "title": "NCCN Lung_nsclc Cancer: insufficient tissue specimen",
        "evidence_type": "guideline",
        "category": "decision_support"
      },
      {
        "id": 30,
        "title": "NCCN Ovarian Cancer: recurrence setting for molecular testing",
        "evidence_type": "guideline",
        "category": "decision_support"
      },
      {
        "id": 31,
        "title": "NCCN Pancreatic Cancer: locally advanced/metastatic disease",
        "evidence_type": "guideline",
        "category": "decision_support"
      },
      {
        "id": 32,
        "title": "NCCN Colorectal Cancer: adjuvant therapy",
        "evidence_type": "guideline",
        "category": "decision_support"
      },
      {
        "id": 33,
        "title": "NCCN Colorectal Cancer: surveillance",
        "evidence_type": "guideline",
        "category": "decision_support"
      },
      {
        "id": 34,
        "title": "NCCN Colorectal Cancer: nonoperative management",
        "evidence_type": "guideline",
        "category": "decision_support"
      },
      {
        "id": 35,
        "title": "Efficacy and safety of brigatinib after alectinib in patients with ALK-positive NSCLC: Integrated analysis of the ALTA-2 and J-ALTA studies.",
        "evidence_type": "RCT",
        "category": "background"
      },
      {
        "id": 36,
        "title": "Liquid biopsy in detecting early non-small cell lung cancer.",
        "evidence_type": "review",
        "category": "background"
      },
      {
        "id": 37,
        "title": "DNA damage and repair (DDR) gene mutation profiles in driver gene wild-type advanced non-small cell lung cancer and the predictive role of response to platinum-based chemotherapy.",
        "evidence_type": "prospective_cohort",
        "category": "background"
      },
      {
        "id": 38,
        "title": "Targeted Therapies in Early-Stage Resectable Non-Small-Cell Lung Cancer: New Kids on the Block.",
        "evidence_type": "review",
        "category": "background"
      },
      {
        "id": 39,
        "title": "Brigatinib Versus Alectinib in ALK-Positive NSCLC After Disease Progression on Crizotinib: Results of Phase 3 ALTA-3 Trial.",
        "evidence_type": "RCT",
        "category": "background"
      },
      {
        "id": 40,
        "title": "Longitudinal monitoring by next-generation sequencing of plasma cell-free DNA in ALK rearranged NSCLC patients treated with ALK tyrosine kinase inhibitors.",
        "evidence_type": "prospective_cohort",
        "category": "policy"
      },
      {
        "id": 41,
        "title": "Efficacy of Brigatinib in Patients With Advanced ALK-Positive NSCLC Who Progressed on Alectinib or Ceritinib: ALK in Lung Cancer Trial of brigAtinib-2 (ALTA-2).",
        "evidence_type": "RCT",
        "category": "background"
      },
      {
        "id": 42,
        "title": "Concordance of Genomic Profiles in Matched Tissue and Plasma Samples From Chinese Patients With Lung Cancer.",
        "evidence_type": "observational",
        "category": "background"
      },
      {
        "id": 94,
        "title": "What's New Related to Drugs",
        "evidence_type": "regulatory",
        "category": "policy"
      },
      {
        "id": 95,
        "title": "Pain and Arthritis Products Containing Hidden Ingredients",
        "evidence_type": "regulatory",
        "category": "policy"
      },
      {
        "id": 96,
        "title": "Abbott Initiates Medical Device Correction for Certain FreeStyle Libre® 3 and FreeStyle Libre 3 Plus Sensors in the U.S.",
        "evidence_type": "regulatory",
        "category": "policy"
      },
      {
        "id": 97,
        "title": "ctDNA-Guided Immunotherapy following Radical Cystectomy for Muscle-Invasive Bladder Cancer: Results from the TOMBOLA Trial",
        "evidence_type": "review",
        "category": "background"
      },
      {
        "id": 98,
        "title": "Prospective Validation of  Circulating Tumor DNA Measurable Residual Disease After First-Line Therapy in Large B-Cell Lymphoma",
        "evidence_type": "review",
        "category": "background"
      },
      {
        "id": 99,
        "title": "Phased Variant–Supported Circulating Tumor DNA as a Prognostic Biomarker After First-Line Treatment in Large B-Cell Lymphoma: Findings From the DIRECT Study",
        "evidence_type": "review",
        "category": "background"
      },
      {
        "id": 100,
        "title": "Tissue-Free Circulating Tumor DNA Assay and Patient Outcome in a Phase III Trial of FOLFOX-Based Adjuvant Chemotherapy (Alliance N0147)",
        "evidence_type": "review",
        "category": "background"
      },
      {
        "id": 101,
        "title": "Precision Oncology 2.0: Guiding Magic Bullets With Expression-Based Liquid Biopsy",
        "evidence_type": "review",
        "category": "background"
      },
      {
        "id": 196,
        "title": "NCT04264702: BESPOKE Study of ctDNA Guided Therapy in Colorectal Cancer",
        "evidence_type": "rct_results",
        "category": "background"
      },
      {
        "id": 197,
        "title": "CIRCULATE: CIRCULATING TUMOR DNA BASED DECISION FOR ADJUVANT TREATMENT IN COLON CANCER STAGE II",
        "evidence_type": "rct_results",
        "category": "background"
      },
      {
        "id": 198,
        "title": "NCT04302025: A Study of Multiple Therapies in Biomarker-selected Participants With Resectable Stages IB-III Non-small Cell Lung Cancer (NSCLC)",
        "evidence_type": "rct_results",
        "category": "background"
      },
      {
        "id": 199,
        "title": "GLORIA: Glucose Homeostasis, Metabolomics and Pregnancy Outcomes After Bariatric Surgery",
        "evidence_type": "rct_results",
        "category": "background"
      },
      {
        "id": 200,
        "title": "MERMAID-1: Phase III Study to Determine the Efficacy of Durvalumab in Combination With Chemotherapy in Completely Resected Stage II-III Non-small Cell Lung Cancer (NSCLC)",
        "evidence_type": "rct_results",
        "category": "background"
      },
      {
        "id": 201,
        "title": "CIRCULATE: Circulating Tumour DNA Based Decision for Adjuvant Treatment in Colon Cancer Stage II Evaluation",
        "evidence_type": "rct_results",
        "category": "background"
      },
      {
        "id": 202,
        "title": "NCT05102045: The Effects of Repetitive Transcranial Magnetic Stimulation in Patients With Alzheimer's Disease",
        "evidence_type": "rct_results",
        "category": "background"
      },
      {
        "id": 203,
        "title": "NCT05078866: Cancer Preventive Vaccine Nous-209 for Lynch Syndrome Patients",
        "evidence_type": "rct_results",
        "category": "background"
      },
      {
        "id": 204,
        "title": "POTENTIATE: Study of the CHK1 Inhibitor BBI-355, an ecDNA-directed Therapy (ecDTx), and the RNR Inhibitor BBI-825, in Subjects With Tumors With Oncogene Amplifications",
        "evidence_type": "rct_results",
        "category": "background"
      },
      {
        "id": 205,
        "title": "NCT03832569: Study of Pembrolizumab Following Surgery in Patients With Microsatellite Instability High (MSI-H) Solid Tumors",
        "evidence_type": "rct_results",
        "category": "background"
      },
      {
        "id": 206,
        "title": "NCT04585477: Adjuvant ctDNA-Adapted Personalized Treatment in Early Stage NSCLC (ADAPT-E)",
        "evidence_type": "rct_results",
        "category": "background"
      },
      {
        "id": 207,
        "title": "FMD: Immersive Virtual Reality in Functional Motor Disorders",
        "evidence_type": "rct_results",
        "category": "background"
      },
      {
        "id": 208,
        "title": "IMPROVE-IT: IMPROVE Intervention Trial Implementing Non-invasive Circulating Tumor DNA Analysis to Optimize the Operative and Postoperative Treatment for Patients With Colorectal Cancer",
        "evidence_type": "rct_results",
        "category": "background"
      },
      {
        "id": 255,
        "title": "ALTAIR: Treatment on Molecular Recurrence (TOMR) with Trifluridine/Tipiracil in Signatera-positive Colorectal Cancer (NCT04457297)",
        "evidence_type": "rct_results",
        "category": "background"
      },
      {
        "id": 256,
        "title": "CIRCULATE-US: Colon Adjuvant Chemotherapy Based on Evaluation of Residual Disease",
        "evidence_type": "rct_ongoing",
        "category": "background"
      },
      {
        "id": 257,
        "title": "NCT03803553: Identification and Treatment Of Micrometastatic Disease in Stage III Colon Cancer",
        "evidence_type": "rct_ongoing",
        "category": "background"
      },
      {
        "id": 258,
        "title": "PLCRC: Prospective Data Collection Initiative on Colorectal Cancer",
        "evidence_type": "rct_ongoing",
        "category": "background"
      },
      {
        "id": 259,
        "title": "CLAUDE: EO2040 in Combination With Nivolumab, for Treatment of Patients With Minimal Residual Disease of Colorectal Cancer",
        "evidence_type": "rct_results",
        "category": "background"
      },
      {
        "id": 260,
        "title": "NCT05060003: Tiragolumab Plus Atezolizumab Versus Atezolizumab in the Treatment of Stage II Melanoma Patients Who Are ctDNA-positive Following Resection",
        "evidence_type": "rct_results",
        "category": "background"
      },
      {
        "id": 261,
        "title": "NCT04786600: A Phase II Randomized Therapeutic Optimization Trial for Subjects With Refractory Metastatic Colorectal Cancer Using ctDNA: Rapid 1 Trial",
        "evidence_type": "rct_results",
        "category": "background"
      },
      {
        "id": 262,
        "title": "AMPLIFY-201: A Study of ELI-002 in Subjects With KRAS Mutated Pancreatic Ductal Adenocarcinoma (PDAC) and Other Solid Tumors",
        "evidence_type": "rct_results",
        "category": "background"
      },
      {
        "id": 263,
        "title": "PERSEVERE: Circulating Tumor DNA Enriched, Genomically Directed Post-neoadjuvant Trial for Patients With Residual Triple Negative Breast Cancer",
        "evidence_type": "rct_results",
        "category": "background"
      },
      {
        "id": 264,
        "title": "ZEST: Efficacy and Safety Comparison of Niraparib to Placebo in Participants With Human Epidermal Growth Factor 2 Negative (HER2-) Breast Cancer Susceptibility Gene Mutation (BRCAmut) or Triple-Negative Breast Cancer (TNBC) With Molecular Disease",
        "evidence_type": "rct_results",
        "category": "background"
      },
      {
        "id": 265,
        "title": "NCT04510285: A Single-Arm Pilot Study of Adjuvant Pembrolizumab Plus Trastuzumab in HER2+ Esophagogastric Tumors With Persistent Circulating Tumor DNA Following Curative Resection",
        "evidence_type": "rct_results",
        "category": "background"
      },
      {
        "id": 266,
        "title": "ALTAIR: Initial Attack on Latent Metastasis Using TAS-102 for ct DNA Identified Colorectal Cancer Patients After Curative Resection",
        "evidence_type": "rct_results",
        "category": "background"
      },
      {
        "id": 267,
        "title": "NCT04068103: Circulating Tumor DNA Testing in Predicting Treatment for Patients With Stage IIA Colon Cancer After Surgery",
        "evidence_type": "rct_results",
        "category": "background"
      },
      {
        "id": 268,
        "title": "NCT02955758: Pembrolizumab in Patients With Metastatic Non-squamous Non-small Cell Lung Cancer",
        "evidence_type": "rct_results",
        "category": "background"
      },
      {
        "id": 269,
        "title": "NCT06939439: Using ctDNA to Guide Treatment Decisions for Stage III Gastric Cancer",
        "evidence_type": "rct_ongoing",
        "category": "background"
      },
      {
        "id": 270,
        "title": "TROPION-Lung12: A Phase III, Randomised Study of Adjuvant Dato-DXd in Combination With Rilvegostomig or Rilvegostomig Monotherapy Versus Standard of Care, Following Complete Tumour Resection, in Participants With Stage I Adenocarcinoma NSCLC Who Are ctDNA-positive or Have High-risk Pathological Features",
        "evidence_type": "rct_ongoing",
        "category": "decision_support"
      },
      {
        "id": 271,
        "title": "TREAT ctDNA: Elacestrant for Treating ER+/HER2- Breast Cancer Patients With ctDNA Relapse (TREAT ctDNA)",
        "evidence_type": "rct_ongoing",
        "category": "background"
      },
      {
        "id": 272,
        "title": "NCT05954078: Circulating Tumor DNA Methylation Guided Postoperative Adjuvant Chemotherapy for High-risk Stage II/III Colorectal Cancer",
        "evidence_type": "rct_ongoing",
        "category": "background"
      },
      {
        "id": 273,
        "title": "NCT05797077: Postoperation Maintenance Therapy for Resectable Liver Metastases of Colorectal Cancer Guided by ctDNA",
        "evidence_type": "rct_ongoing",
        "category": "background"
      },
      {
        "id": 274,
        "title": "CLAUDIA: Platform Study of Circulating Tumor DNA Directed Adjuvant Chemotherapy in Colon Cancer (KCSG CO22-12)",
        "evidence_type": "rct_ongoing",
        "category": "background"
      },
      {
        "id": 275,
        "title": "APPROACH: MRD Guiding Treatment After Almonertinib Induction Therapy for EGFRm+ Stage III NSCLC in the MDT Diagnostic Model.",
        "evidence_type": "rct_ongoing",
        "category": "background"
      },
      {
        "id": 276,
        "title": "SERENA-6: Phase III Study to Assess AZD9833+ CDK4/6 Inhibitor in HR+/HER2-MBC With Detectable ESR1m Before Progression (SERENA-6)",
        "evidence_type": "rct_ongoing",
        "category": "background"
      },
      {
        "id": 277,
        "title": "Artemis: A Prospective, Phase II Trial Using ctDNA to Initiate Post-operation Boost Therapy After Adjuvant Chemotherapy in TNBC",
        "evidence_type": "rct_ongoing",
        "category": "background"
      },
      {
        "id": 278,
        "title": "NCT04093167: Study of CTDNA Response Adaptive Immuno-Chemotherapy in NSCLC",
        "evidence_type": "rct_ongoing",
        "category": "background"
      },
      {
        "id": 279,
        "title": "BioItaLEE: Study of the Molecular Features of Postmenopausal Women With HR+ HER2-negative aBC on First-line Treatment With Ribociclib and Letrozole and, in Patients With a PIK3CA Mutation, on Second-line Treatment With Alpelisib Plus Fulvestrant",
        "evidence_type": "rct_ongoing",
        "category": "background"
      },
      {
        "id": 280,
        "title": "NCT01462994: Detection of CF-DNA in Patients With Gastrointestinal Stromal Tumors (GIST)",
        "evidence_type": "rct_ongoing",
        "category": "background"
      }
    ]
  },
  "items": [
    {
      "id": 1,
      "title": "NCCN Bladder Cancer: post-cystectomy surveillance",
      "source_type": "nccn",
      "source_id": "nccn-bladder-1770048977156-0",
      "evidence_type": "guideline",
      "is_superseded": false,
      "cancer_types": [
        "bladder"
      ],
      "clinical_settings": [
        "post-cystectomy surveillance"
      ],
      "questions": [],
      "classification": {
        "category": "decision_support",
        "decisionPoints": [],
        "cancerTypeStage": [
          "bladder"
        ],
        "testSpecific": []
      },
      "has_decision_context": false,
      "has_direct_quotes": false,
      "has_guardrail": false
    },
    {
      "id": 2,
      "title": "NCCN Bladder Cancer: advanced/metastatic disease monitoring",
      "source_type": "nccn",
      "source_id": "nccn-bladder-1770048977422-1",
      "evidence_type": "guideline",
      "is_superseded": false,
      "cancer_types": [
        "bladder"
      ],
      "clinical_settings": [
        "advanced/metastatic disease monitoring"
      ],
      "questions": [],
      "classification": {
        "category": "decision_support",
        "decisionPoints": [],
        "cancerTypeStage": [
          "bladder"
        ],
        "testSpecific": []
      },
      "has_decision_context": false,
      "has_direct_quotes": false,
      "has_guardrail": false
    },
    {
      "id": 3,
      "title": "NCCN Bladder Cancer: advanced disease treatment decisions",
      "source_type": "nccn",
      "source_id": "nccn-bladder-1770048977609-2",
      "evidence_type": "guideline",
      "is_superseded": false,
      "cancer_types": [
        "bladder"
      ],
      "clinical_settings": [
        "advanced disease treatment decisions"
      ],
      "questions": [],
      "classification": {
        "category": "decision_support",
        "decisionPoints": [],
        "cancerTypeStage": [
          "bladder"
        ],
        "testSpecific": []
      },
      "has_decision_context": false,
      "has_direct_quotes": false,
      "has_guardrail": false
    },
    {
      "id": 4,
      "title": "NCCN Breast Cancer: metastatic disease progression on endocrine therapy",
      "source_type": "nccn",
      "source_id": "nccn-breast-1770048977789-3",
      "evidence_type": "guideline",
      "is_superseded": false,
      "cancer_types": [
        "breast"
      ],
      "clinical_settings": [],
      "questions": [],
      "classification": {
        "category": "decision_support",
        "decisionPoints": [],
        "cancerTypeStage": [
          "breast"
        ],
        "testSpecific": []
      },
      "has_decision_context": false,
      "has_direct_quotes": false,
      "has_guardrail": false
    },
    {
      "id": 5,
      "title": "NCCN Breast Cancer: metastatic disease when ctDNA shows ESR1 negative with low tumor fraction",
      "source_type": "nccn",
      "source_id": "nccn-breast-1770048977993-4",
      "evidence_type": "guideline",
      "is_superseded": false,
      "cancer_types": [
        "breast"
      ],
      "clinical_settings": [],
      "questions": [],
      "classification": {
        "category": "decision_support",
        "decisionPoints": [],
        "cancerTypeStage": [
          "breast"
        ],
        "testSpecific": []
      },
      "has_decision_context": false,
      "has_direct_quotes": false,
      "has_guardrail": false
    },
    {
      "id": 6,
      "title": "NCCN Breast Cancer: metastatic disease biomarker testing",
      "source_type": "nccn",
      "source_id": "nccn-breast-1770048978131-5",
      "evidence_type": "guideline",
      "is_superseded": false,
      "cancer_types": [
        "breast"
      ],
      "clinical_settings": [
        "metastatic disease biomarker testing"
      ],
      "questions": [],
      "classification": {
        "category": "decision_support",
        "decisionPoints": [],
        "cancerTypeStage": [
          "breast"
        ],
        "testSpecific": []
      },
      "has_decision_context": false,
      "has_direct_quotes": false,
      "has_guardrail": false
    },
    {
      "id": 7,
      "title": "NCCN Breast Cancer: ctDNA testing interpretation",
      "source_type": "nccn",
      "source_id": "nccn-breast-1770048978306-6",
      "evidence_type": "guideline",
      "is_superseded": false,
      "cancer_types": [
        "breast"
      ],
      "clinical_settings": [
        "ctDNA testing interpretation"
      ],
      "questions": [],
      "classification": {
        "category": "decision_support",
        "decisionPoints": [],
        "cancerTypeStage": [
          "breast"
        ],
        "testSpecific": []
      },
      "has_decision_context": false,
      "has_direct_quotes": false,
      "has_guardrail": false
    },
    {
      "id": 8,
      "title": "NCCN Breast Cancer: ctDNA testing with low tumor fraction",
      "source_type": "nccn",
      "source_id": "nccn-breast-1770048978563-7",
      "evidence_type": "guideline",
      "is_superseded": false,
      "cancer_types": [
        "breast"
      ],
      "clinical_settings": [
        "ctDNA testing with low tumor fraction"
      ],
      "questions": [],
      "classification": {
        "category": "decision_support",
        "decisionPoints": [],
        "cancerTypeStage": [
          "breast"
        ],
        "testSpecific": []
      },
      "has_decision_context": false,
      "has_direct_quotes": false,
      "has_guardrail": false
    },
    {
      "id": 9,
      "title": "NCCN Colorectal Cancer: surveillance",
      "source_type": "nccn",
      "source_id": "nccn-colorectal-1770048978747-8",
      "evidence_type": "guideline",
      "is_superseded": false,
      "cancer_types": [
        "colorectal"
      ],
      "clinical_settings": [
        "surveillance"
      ],
      "questions": [],
      "classification": {
        "category": "decision_support",
        "decisionPoints": [],
        "cancerTypeStage": [
          "colorectal"
        ],
        "testSpecific": []
      },
      "has_decision_context": false,
      "has_direct_quotes": false,
      "has_guardrail": false
    },
    {
      "id": 10,
      "title": "NCCN Colorectal Cancer: adjuvant therapy and surveillance",
      "source_type": "nccn",
      "source_id": "nccn-colorectal-1770048978997-9",
      "evidence_type": "guideline",
      "is_superseded": false,
      "cancer_types": [
        "colorectal"
      ],
      "clinical_settings": [
        "adjuvant therapy and surveillance"
      ],
      "questions": [],
      "classification": {
        "category": "decision_support",
        "decisionPoints": [],
        "cancerTypeStage": [
          "colorectal"
        ],
        "testSpecific": []
      },
      "has_decision_context": false,
      "has_direct_quotes": false,
      "has_guardrail": false
    },
    {
      "id": 11,
      "title": "NCCN Colorectal Cancer: adjuvant therapy and surveillance",
      "source_type": "nccn",
      "source_id": "nccn-colorectal-1770048979186-10",
      "evidence_type": "guideline",
      "is_superseded": false,
      "cancer_types": [
        "colorectal"
      ],
      "clinical_settings": [
        "adjuvant therapy and surveillance"
      ],
      "questions": [],
      "classification": {
        "category": "decision_support",
        "decisionPoints": [],
        "cancerTypeStage": [
          "colorectal"
        ],
        "testSpecific": []
      },
      "has_decision_context": false,
      "has_direct_quotes": false,
      "has_guardrail": false
    },
    {
      "id": 12,
      "title": "NCCN Colorectal Cancer: adjuvant therapy",
      "source_type": "nccn",
      "source_id": "nccn-colorectal-1770048979368-11",
      "evidence_type": "guideline",
      "is_superseded": false,
      "cancer_types": [
        "colorectal"
      ],
      "clinical_settings": [
        "adjuvant therapy"
      ],
      "questions": [],
      "classification": {
        "category": "decision_support",
        "decisionPoints": [],
        "cancerTypeStage": [
          "colorectal_stage_II"
        ],
        "testSpecific": []
      },
      "has_decision_context": false,
      "has_direct_quotes": false,
      "has_guardrail": false
    },
    {
      "id": 13,
      "title": "NCCN Melanoma Cancer: molecular testing for targetable mutations",
      "source_type": "nccn",
      "source_id": "nccn-melanoma-1770048979617-12",
      "evidence_type": "guideline",
      "is_superseded": false,
      "cancer_types": [
        "melanoma"
      ],
      "clinical_settings": [
        "molecular testing for targetable mutations"
      ],
      "questions": [],
      "classification": {
        "category": "decision_support",
        "decisionPoints": [],
        "cancerTypeStage": [
          "melanoma"
        ],
        "testSpecific": []
      },
      "has_decision_context": false,
      "has_direct_quotes": false,
      "has_guardrail": false
    },
    {
      "id": 14,
      "title": "NCCN Melanoma Cancer: molecular testing when liquid biopsy is negative",
      "source_type": "nccn",
      "source_id": "nccn-melanoma-1770048979812-13",
      "evidence_type": "guideline",
      "is_superseded": false,
      "cancer_types": [
        "melanoma"
      ],
      "clinical_settings": [
        "molecular testing when liquid biopsy is negative"
      ],
      "questions": [],
      "classification": {
        "category": "decision_support",
        "decisionPoints": [],
        "cancerTypeStage": [
          "melanoma"
        ],
        "testSpecific": []
      },
      "has_decision_context": false,
      "has_direct_quotes": false,
      "has_guardrail": false
    },
    {
      "id": 15,
      "title": "NCCN Esophageal Cancer: metastatic or advanced disease",
      "source_type": "nccn",
      "source_id": "nccn-esophageal-1770048980043-14",
      "evidence_type": "guideline",
      "is_superseded": false,
      "cancer_types": [
        "esophageal"
      ],
      "clinical_settings": [
        "metastatic or advanced disease"
      ],
      "questions": [],
      "classification": {
        "category": "decision_support",
        "decisionPoints": [],
        "cancerTypeStage": [
          "esophageal"
        ],
        "testSpecific": []
      },
      "has_decision_context": false,
      "has_direct_quotes": false,
      "has_guardrail": false
    },
    {
      "id": 16,
      "title": "NCCN Esophageal Cancer: surveillance/monitoring",
      "source_type": "nccn",
      "source_id": "nccn-esophageal-1770048980230-15",
      "evidence_type": "guideline",
      "is_superseded": false,
      "cancer_types": [
        "esophageal"
      ],
      "clinical_settings": [
        "surveillance/monitoring"
      ],
      "questions": [],
      "classification": {
        "category": "decision_support",
        "decisionPoints": [],
        "cancerTypeStage": [
          "esophageal"
        ],
        "testSpecific": []
      },
      "has_decision_context": false,
      "has_direct_quotes": false,
      "has_guardrail": false
    },
    {
      "id": 17,
      "title": "NCCN Esophageal Cancer: general interpretation",
      "source_type": "nccn",
      "source_id": "nccn-esophageal-1770048980406-16",
      "evidence_type": "guideline",
      "is_superseded": false,
      "cancer_types": [
        "esophageal"
      ],
      "clinical_settings": [
        "general interpretation"
      ],
      "questions": [],
      "classification": {
        "category": "decision_support",
        "decisionPoints": [],
        "cancerTypeStage": [
          "esophageal"
        ],
        "testSpecific": []
      },
      "has_decision_context": false,
      "has_direct_quotes": false,
      "has_guardrail": false
    },
    {
      "id": 18,
      "title": "NCCN Gastric Cancer: metastatic or advanced gastric cancer",
      "source_type": "nccn",
      "source_id": "nccn-gastric-1770048980654-17",
      "evidence_type": "guideline",
      "is_superseded": false,
      "cancer_types": [
        "gastric"
      ],
      "clinical_settings": [
        "metastatic or advanced gastric cancer"
      ],
      "questions": [],
      "classification": {
        "category": "decision_support",
        "decisionPoints": [],
        "cancerTypeStage": [
          "gastric"
        ],
        "testSpecific": []
      },
      "has_decision_context": false,
      "has_direct_quotes": false,
      "has_guardrail": false
    },
    {
      "id": 19,
      "title": "NCCN Gastric Cancer: preoperative therapy monitoring",
      "source_type": "nccn",
      "source_id": "nccn-gastric-1770048980832-18",
      "evidence_type": "guideline",
      "is_superseded": false,
      "cancer_types": [
        "gastric"
      ],
      "clinical_settings": [
        "preoperative therapy monitoring"
      ],
      "questions": [],
      "classification": {
        "category": "decision_support",
        "decisionPoints": [],
        "cancerTypeStage": [
          "gastric"
        ],
        "testSpecific": []
      },
      "has_decision_context": false,
      "has_direct_quotes": false,
      "has_guardrail": false
    },
    {
      "id": 20,
      "title": "NCCN Head_neck Cancer: nasopharyngeal carcinoma management",
      "source_type": "nccn",
      "source_id": "nccn-head_neck-1770048981096-19",
      "evidence_type": "guideline",
      "is_superseded": false,
      "cancer_types": [
        "head_neck"
      ],
      "clinical_settings": [
        "nasopharyngeal carcinoma management"
      ],
      "questions": [],
      "classification": {
        "category": "decision_support",
        "decisionPoints": [],
        "cancerTypeStage": [
          "head_neck"
        ],
        "testSpecific": []
      },
      "has_decision_context": false,
      "has_direct_quotes": false,
      "has_guardrail": false
    },
    {
      "id": 21,
      "title": "NCCN Head_neck Cancer: post-treatment surveillance",
      "source_type": "nccn",
      "source_id": "nccn-head_neck-1770048981276-20",
      "evidence_type": "guideline",
      "is_superseded": false,
      "cancer_types": [
        "head_neck"
      ],
      "clinical_settings": [
        "post-treatment surveillance"
      ],
      "questions": [],
      "classification": {
        "category": "decision_support",
        "decisionPoints": [],
        "cancerTypeStage": [
          "head_neck"
        ],
        "testSpecific": []
      },
      "has_decision_context": false,
      "has_direct_quotes": false,
      "has_guardrail": false
    },
    {
      "id": 22,
      "title": "NCCN Head_neck Cancer: induction chemotherapy monitoring",
      "source_type": "nccn",
      "source_id": "nccn-head_neck-1770048981456-21",
      "evidence_type": "guideline",
      "is_superseded": false,
      "cancer_types": [
        "head_neck"
      ],
      "clinical_settings": [
        "induction chemotherapy monitoring"
      ],
      "questions": [],
      "classification": {
        "category": "decision_support",
        "decisionPoints": [],
        "cancerTypeStage": [
          "head_neck"
        ],
        "testSpecific": []
      },
      "has_decision_context": false,
      "has_direct_quotes": false,
      "has_guardrail": false
    },
    {
      "id": 23,
      "title": "NCCN Head_neck Cancer: advanced nasopharyngeal carcinoma",
      "source_type": "nccn",
      "source_id": "nccn-head_neck-1770048981706-22",
      "evidence_type": "guideline",
      "is_superseded": false,
      "cancer_types": [
        "head_neck"
      ],
      "clinical_settings": [
        "advanced nasopharyngeal carcinoma"
      ],
      "questions": [],
      "classification": {
        "category": "decision_support",
        "decisionPoints": [],
        "cancerTypeStage": [
          "head_neck"
        ],
        "testSpecific": []
      },
      "has_decision_context": false,
      "has_direct_quotes": false,
      "has_guardrail": false
    },
    {
      "id": 24,
      "title": "NCCN Lung_nsclc Cancer: general testing principles",
      "source_type": "nccn",
      "source_id": "nccn-lung_nsclc-1770048981884-23",
      "evidence_type": "guideline",
      "is_superseded": false,
      "cancer_types": [
        "lung_nsclc"
      ],
      "clinical_settings": [
        "general testing principles"
      ],
      "questions": [],
      "classification": {
        "category": "decision_support",
        "decisionPoints": [],
        "cancerTypeStage": [
          "lung_nsclc"
        ],
        "testSpecific": []
      },
      "has_decision_context": false,
      "has_direct_quotes": false,
      "has_guardrail": false
    },
    {
      "id": 25,
      "title": "NCCN Lung_nsclc Cancer: early stage disease",
      "source_type": "nccn",
      "source_id": "nccn-lung_nsclc-1770048982142-24",
      "evidence_type": "guideline",
      "is_superseded": false,
      "cancer_types": [
        "lung_nsclc"
      ],
      "clinical_settings": [
        "early stage disease"
      ],
      "questions": [],
      "classification": {
        "category": "decision_support",
        "decisionPoints": [],
        "cancerTypeStage": [
          "lung_nsclc"
        ],
        "testSpecific": []
      },
      "has_decision_context": false,
      "has_direct_quotes": false,
      "has_guardrail": false
    },
    {
      "id": 26,
      "title": "NCCN Lung_nsclc Cancer: thoracic metastatic disease",
      "source_type": "nccn",
      "source_id": "nccn-lung_nsclc-1770048982323-25",
      "evidence_type": "guideline",
      "is_superseded": false,
      "cancer_types": [
        "lung_nsclc"
      ],
      "clinical_settings": [
        "thoracic metastatic disease"
      ],
      "questions": [],
      "classification": {
        "category": "decision_support",
        "decisionPoints": [],
        "cancerTypeStage": [
          "lung_nsclc"
        ],
        "testSpecific": []
      },
      "has_decision_context": false,
      "has_direct_quotes": false,
      "has_guardrail": false
    },
    {
      "id": 27,
      "title": "NCCN Lung_nsclc Cancer: advanced/metastatic disease",
      "source_type": "nccn",
      "source_id": "nccn-lung_nsclc-1770048982501-26",
      "evidence_type": "guideline",
      "is_superseded": false,
      "cancer_types": [
        "lung_nsclc"
      ],
      "clinical_settings": [
        "advanced/metastatic disease"
      ],
      "questions": [],
      "classification": {
        "category": "decision_support",
        "decisionPoints": [],
        "cancerTypeStage": [
          "lung_nsclc"
        ],
        "testSpecific": []
      },
      "has_decision_context": false,
      "has_direct_quotes": false,
      "has_guardrail": false
    },
    {
      "id": 28,
      "title": "NCCN Lung_nsclc Cancer: progression on targeted therapy",
      "source_type": "nccn",
      "source_id": "nccn-lung_nsclc-1770048982755-27",
      "evidence_type": "guideline",
      "is_superseded": false,
      "cancer_types": [
        "lung_nsclc"
      ],
      "clinical_settings": [
        "progression on targeted therapy"
      ],
      "questions": [],
      "classification": {
        "category": "decision_support",
        "decisionPoints": [],
        "cancerTypeStage": [
          "lung_nsclc"
        ],
        "testSpecific": []
      },
      "has_decision_context": false,
      "has_direct_quotes": false,
      "has_guardrail": false
    },
    {
      "id": 29,
      "title": "NCCN Lung_nsclc Cancer: insufficient tissue specimen",
      "source_type": "nccn",
      "source_id": "nccn-lung_nsclc-1770048982931-28",
      "evidence_type": "guideline",
      "is_superseded": false,
      "cancer_types": [
        "lung_nsclc"
      ],
      "clinical_settings": [
        "insufficient tissue specimen"
      ],
      "questions": [],
      "classification": {
        "category": "decision_support",
        "decisionPoints": [],
        "cancerTypeStage": [
          "lung_nsclc"
        ],
        "testSpecific": []
      },
      "has_decision_context": false,
      "has_direct_quotes": false,
      "has_guardrail": false
    },
    {
      "id": 30,
      "title": "NCCN Ovarian Cancer: recurrence setting for molecular testing",
      "source_type": "nccn",
      "source_id": "nccn-ovarian-1770048983190-29",
      "evidence_type": "guideline",
      "is_superseded": false,
      "cancer_types": [
        "ovarian"
      ],
      "clinical_settings": [
        "recurrence setting for molecular testing"
      ],
      "questions": [],
      "classification": {
        "category": "decision_support",
        "decisionPoints": [],
        "cancerTypeStage": [
          "ovarian"
        ],
        "testSpecific": []
      },
      "has_decision_context": false,
      "has_direct_quotes": false,
      "has_guardrail": false
    },
    {
      "id": 31,
      "title": "NCCN Pancreatic Cancer: locally advanced/metastatic disease",
      "source_type": "nccn",
      "source_id": "nccn-pancreatic-1770048983372-30",
      "evidence_type": "guideline",
      "is_superseded": false,
      "cancer_types": [
        "pancreatic"
      ],
      "clinical_settings": [
        "locally advanced/metastatic disease"
      ],
      "questions": [],
      "classification": {
        "category": "decision_support",
        "decisionPoints": [],
        "cancerTypeStage": [
          "pancreatic"
        ],
        "testSpecific": []
      },
      "has_decision_context": false,
      "has_direct_quotes": false,
      "has_guardrail": false
    },
    {
      "id": 32,
      "title": "NCCN Colorectal Cancer: adjuvant therapy",
      "source_type": "nccn",
      "source_id": "nccn-colorectal-1770048983549-31",
      "evidence_type": "guideline",
      "is_superseded": false,
      "cancer_types": [
        "colorectal"
      ],
      "clinical_settings": [
        "adjuvant therapy"
      ],
      "questions": [],
      "classification": {
        "category": "decision_support",
        "decisionPoints": [],
        "cancerTypeStage": [
          "colorectal"
        ],
        "testSpecific": []
      },
      "has_decision_context": false,
      "has_direct_quotes": false,
      "has_guardrail": false
    },
    {
      "id": 33,
      "title": "NCCN Colorectal Cancer: surveillance",
      "source_type": "nccn",
      "source_id": "nccn-colorectal-1770048983807-32",
      "evidence_type": "guideline",
      "is_superseded": false,
      "cancer_types": [
        "colorectal"
      ],
      "clinical_settings": [
        "surveillance"
      ],
      "questions": [],
      "classification": {
        "category": "decision_support",
        "decisionPoints": [],
        "cancerTypeStage": [
          "colorectal"
        ],
        "testSpecific": []
      },
      "has_decision_context": false,
      "has_direct_quotes": false,
      "has_guardrail": false
    },
    {
      "id": 34,
      "title": "NCCN Colorectal Cancer: nonoperative management",
      "source_type": "nccn",
      "source_id": "nccn-colorectal-1770048983994-33",
      "evidence_type": "guideline",
      "is_superseded": false,
      "cancer_types": [
        "colorectal"
      ],
      "clinical_settings": [
        "nonoperative management"
      ],
      "questions": [],
      "classification": {
        "category": "decision_support",
        "decisionPoints": [],
        "cancerTypeStage": [
          "colorectal"
        ],
        "testSpecific": []
      },
      "has_decision_context": false,
      "has_direct_quotes": false,
      "has_guardrail": false
    },
    {
      "id": 35,
      "title": "Efficacy and safety of brigatinib after alectinib in patients with ALK-positive NSCLC: Integrated analysis of the ALTA-2 and J-ALTA studies.",
      "source_type": "pubmed",
      "source_id": "41110382",
      "evidence_type": "RCT",
      "is_superseded": false,
      "cancer_types": [
        "lung_nsclc",
        "multi_solid"
      ],
      "clinical_settings": [
        "metastatic"
      ],
      "questions": [],
      "classification": {
        "category": "background",
        "decisionPoints": [],
        "cancerTypeStage": [
          "lung_nsclc",
          "multi_solid"
        ],
        "testSpecific": []
      },
      "has_decision_context": false,
      "has_direct_quotes": false,
      "has_guardrail": false
    },
    {
      "id": 36,
      "title": "Liquid biopsy in detecting early non-small cell lung cancer.",
      "source_type": "pubmed",
      "source_id": "40027282",
      "evidence_type": "review",
      "is_superseded": false,
      "cancer_types": [
        "lung_nsclc",
        "lung_sclc",
        "multi_solid",
        "sarcoma"
      ],
      "clinical_settings": [
        "treatment_response",
        "metastatic"
      ],
      "questions": [],
      "classification": {
        "category": "background",
        "decisionPoints": [],
        "cancerTypeStage": [
          "lung_nsclc",
          "lung_sclc",
          "multi_solid",
          "sarcoma"
        ],
        "testSpecific": []
      },
      "has_decision_context": false,
      "has_direct_quotes": false,
      "has_guardrail": false
    },
    {
      "id": 37,
      "title": "DNA damage and repair (DDR) gene mutation profiles in driver gene wild-type advanced non-small cell lung cancer and the predictive role of response to platinum-based chemotherapy.",
      "source_type": "pubmed",
      "source_id": "40386740",
      "evidence_type": "prospective_cohort",
      "is_superseded": false,
      "cancer_types": [
        "lung_nsclc",
        "lung_sclc",
        "multi_solid"
      ],
      "clinical_settings": [
        "metastatic",
        "surveillance"
      ],
      "questions": [],
      "classification": {
        "category": "background",
        "decisionPoints": [],
        "cancerTypeStage": [
          "lung_nsclc",
          "lung_sclc",
          "multi_solid"
        ],
        "testSpecific": []
      },
      "has_decision_context": false,
      "has_direct_quotes": false,
      "has_guardrail": false
    },
    {
      "id": 38,
      "title": "Targeted Therapies in Early-Stage Resectable Non-Small-Cell Lung Cancer: New Kids on the Block.",
      "source_type": "pubmed",
      "source_id": "37656950",
      "evidence_type": "review",
      "is_superseded": false,
      "cancer_types": [
        "lung_nsclc",
        "lung_sclc",
        "multi_solid"
      ],
      "clinical_settings": [
        "adjuvant",
        "neoadjuvant",
        "treatment_selection"
      ],
      "questions": [],
      "classification": {
        "category": "background",
        "decisionPoints": [],
        "cancerTypeStage": [
          "lung_nsclc",
          "lung_sclc",
          "multi_solid"
        ],
        "testSpecific": []
      },
      "has_decision_context": false,
      "has_direct_quotes": false,
      "has_guardrail": false
    },
    {
      "id": 39,
      "title": "Brigatinib Versus Alectinib in ALK-Positive NSCLC After Disease Progression on Crizotinib: Results of Phase 3 ALTA-3 Trial.",
      "source_type": "pubmed",
      "source_id": "37574132",
      "evidence_type": "RCT",
      "is_superseded": false,
      "cancer_types": [
        "lung_nsclc",
        "multi_solid"
      ],
      "clinical_settings": [
        "metastatic"
      ],
      "questions": [],
      "classification": {
        "category": "background",
        "decisionPoints": [],
        "cancerTypeStage": [
          "lung_nsclc",
          "multi_solid"
        ],
        "testSpecific": []
      },
      "has_decision_context": false,
      "has_direct_quotes": false,
      "has_guardrail": false
    },
    {
      "id": 40,
      "title": "Longitudinal monitoring by next-generation sequencing of plasma cell-free DNA in ALK rearranged NSCLC patients treated with ALK tyrosine kinase inhibitors.",
      "source_type": "pubmed",
      "source_id": "35437925",
      "evidence_type": "prospective_cohort",
      "is_superseded": false,
      "cancer_types": [
        "lung_nsclc",
        "lung_sclc",
        "multi_solid"
      ],
      "clinical_settings": [
        "surveillance"
      ],
      "questions": [],
      "classification": {
        "category": "policy",
        "decisionPoints": [],
        "cancerTypeStage": [
          "lung_nsclc",
          "lung_sclc",
          "multi_solid"
        ],
        "testSpecific": [
          "Guardant360"
        ]
      },
      "has_decision_context": false,
      "has_direct_quotes": false,
      "has_guardrail": false
    },
    {
      "id": 41,
      "title": "Efficacy of Brigatinib in Patients With Advanced ALK-Positive NSCLC Who Progressed on Alectinib or Ceritinib: ALK in Lung Cancer Trial of brigAtinib-2 (ALTA-2).",
      "source_type": "pubmed",
      "source_id": "36096442",
      "evidence_type": "RCT",
      "is_superseded": false,
      "cancer_types": [
        "lung_nsclc",
        "multi_solid"
      ],
      "clinical_settings": [
        "surveillance",
        "metastatic"
      ],
      "questions": [],
      "classification": {
        "category": "background",
        "decisionPoints": [],
        "cancerTypeStage": [
          "lung_nsclc",
          "multi_solid"
        ],
        "testSpecific": []
      },
      "has_decision_context": false,
      "has_direct_quotes": false,
      "has_guardrail": false
    },
    {
      "id": 42,
      "title": "Concordance of Genomic Profiles in Matched Tissue and Plasma Samples From Chinese Patients With Lung Cancer.",
      "source_type": "pubmed",
      "source_id": "36310733",
      "evidence_type": "observational",
      "is_superseded": false,
      "cancer_types": [
        "lung_nsclc",
        "multi_solid",
        "sarcoma"
      ],
      "clinical_settings": [],
      "questions": [],
      "classification": {
        "category": "background",
        "decisionPoints": [],
        "cancerTypeStage": [
          "lung_nsclc",
          "multi_solid",
          "sarcoma"
        ],
        "testSpecific": []
      },
      "has_decision_context": false,
      "has_direct_quotes": false,
      "has_guardrail": false
    },
    {
      "id": 43,
      "title": "MolDX: Inivata™, InVisionFirst®, Liquid Biopsy for Patients with Lung Cancer",
      "source_type": "payer-moldx-palmetto",
      "source_id": "cms-L37870-v19",
      "evidence_type": "payer_policy",
      "is_superseded": false,
      "cancer_types": [
        "lung_nsclc",
        "multi_solid"
      ],
      "clinical_settings": [
        "coverage_determination"
      ],
      "questions": [],
      "classification": {
        "category": "policy",
        "decisionPoints": [],
        "cancerTypeStage": [
          "lung_nsclc",
          "multi_solid"
        ],
        "testSpecific": []
      },
      "has_decision_context": true,
      "has_direct_quotes": false,
      "has_guardrail": false
    },
    {
      "id": 44,
      "title": "MolDX: Phenotypic Biomarker Detection from Circulating Tumor Cells",
      "source_type": "payer-moldx-cgs",
      "source_id": "cms-L38584-v14",
      "evidence_type": "payer_policy",
      "is_superseded": false,
      "cancer_types": [
        "multi_solid"
      ],
      "clinical_settings": [
        "coverage_determination"
      ],
      "questions": [],
      "classification": {
        "category": "policy",
        "decisionPoints": [],
        "cancerTypeStage": [
          "multi_solid"
        ],
        "testSpecific": []
      },
      "has_decision_context": true,
      "has_direct_quotes": false,
      "has_guardrail": false
    },
    {
      "id": 45,
      "title": "MolDX: Minimal Residual Disease Testing for Cancer",
      "source_type": "payer-moldx-cgs",
      "source_id": "cms-L38822-v8",
      "evidence_type": "payer_policy",
      "is_superseded": false,
      "cancer_types": [
        "multi_solid"
      ],
      "clinical_settings": [
        "coverage_determination"
      ],
      "questions": [],
      "classification": {
        "category": "policy",
        "decisionPoints": [],
        "cancerTypeStage": [
          "multi_solid"
        ],
        "testSpecific": []
      },
      "has_decision_context": true,
      "has_direct_quotes": false,
      "has_guardrail": false
    },
    {
      "id": 46,
      "title": "MolDX: Phenotypic Biomarker Detection in Circulating Tumor Cells",
      "source_type": "payer-moldx-palmetto",
      "source_id": "cms-L38566-v11",
      "evidence_type": "payer_policy",
      "is_superseded": false,
      "cancer_types": [
        "multi_solid"
      ],
      "clinical_settings": [
        "coverage_determination"
      ],
      "questions": [],
      "classification": {
        "category": "policy",
        "decisionPoints": [],
        "cancerTypeStage": [
          "multi_solid"
        ],
        "testSpecific": []
      },
      "has_decision_context": true,
      "has_direct_quotes": false,
      "has_guardrail": false
    },
    {
      "id": 47,
      "title": "Billing and Coding: MolDX: Minimal Residual Disease Testing for Solid Tumor Cancers",
      "source_type": "payer-moldx-palmetto",
      "source_id": "cms-A58376-v59",
      "evidence_type": "billing_guidance",
      "is_superseded": false,
      "cancer_types": [
        "multi_solid"
      ],
      "clinical_settings": [
        "coverage_determination"
      ],
      "questions": [],
      "classification": {
        "category": "policy",
        "decisionPoints": [],
        "cancerTypeStage": [
          "multi_solid"
        ],
        "testSpecific": []
      },
      "has_decision_context": true,
      "has_direct_quotes": false,
      "has_guardrail": false
    },
    {
      "id": 48,
      "title": "Billing and Coding: MolDX: Minimal Residual Disease Testing for Hematologic Cancers",
      "source_type": "payer-moldx-noridian",
      "source_id": "cms-A58996-v30",
      "evidence_type": "billing_guidance",
      "is_superseded": false,
      "cancer_types": [
        "multi_solid"
      ],
      "clinical_settings": [
        "coverage_determination"
      ],
      "questions": [],
      "classification": {
        "category": "policy",
        "decisionPoints": [],
        "cancerTypeStage": [
          "multi_solid"
        ],
        "testSpecific": []
      },
      "has_decision_context": true,
      "has_direct_quotes": false,
      "has_guardrail": false
    },
    {
      "id": 49,
      "title": "Response to Comments: MolDX: Minimal Residual Disease Testing for Cancer",
      "source_type": "payer-moldx-palmetto",
      "source_id": "cms-A58915-v7",
      "evidence_type": "billing_article",
      "is_superseded": false,
      "cancer_types": [
        "multi_solid"
      ],
      "clinical_settings": [
        "coverage_determination"
      ],
      "questions": [],
      "classification": {
        "category": "policy",
        "decisionPoints": [],
        "cancerTypeStage": [
          "multi_solid"
        ],
        "testSpecific": []
      },
      "has_decision_context": true,
      "has_direct_quotes": false,
      "has_guardrail": false
    },
    {
      "id": 50,
      "title": "Response to Comments: MolDX: Minimal Residual Disease Testing for Cancer (DL38835)",
      "source_type": "payer-medicare-lcd",
      "source_id": "cms-A58930-v2",
      "evidence_type": "billing_article",
      "is_superseded": false,
      "cancer_types": [
        "multi_solid"
      ],
      "clinical_settings": [
        "coverage_determination"
      ],
      "questions": [],
      "classification": {
        "category": "policy",
        "decisionPoints": [],
        "cancerTypeStage": [
          "multi_solid"
        ],
        "testSpecific": []
      },
      "has_decision_context": true,
      "has_direct_quotes": false,
      "has_guardrail": false
    },
    {
      "id": 51,
      "title": "Response to Comments: MolDX: Minimal Residual Disease Testing for Colorectal Cancer",
      "source_type": "payer-medicare-lcd",
      "source_id": "cms-A58416-v2",
      "evidence_type": "billing_article",
      "is_superseded": false,
      "cancer_types": [
        "colorectal",
        "multi_solid"
      ],
      "clinical_settings": [
        "coverage_determination"
      ],
      "questions": [],
      "classification": {
        "category": "policy",
        "decisionPoints": [],
        "cancerTypeStage": [
          "colorectal",
          "multi_solid"
        ],
        "testSpecific": []
      },
      "has_decision_context": true,
      "has_direct_quotes": false,
      "has_guardrail": false
    },
    {
      "id": 52,
      "title": "NCCN Bladder Cancer: advanced disease treatment monitoring",
      "source_type": "nccn",
      "source_id": "nccn-bladder-3.2025-1770067594316",
      "evidence_type": "guideline",
      "is_superseded": false,
      "cancer_types": [],
      "clinical_settings": [],
      "questions": [],
      "classification": {
        "category": "decision_support",
        "decisionPoints": [],
        "cancerTypeStage": [],
        "testSpecific": []
      },
      "has_decision_context": true,
      "has_direct_quotes": true,
      "has_guardrail": false
    },
    {
      "id": 53,
      "title": "NCCN Breast Cancer: progression following prior lines of endocrine therapy",
      "source_type": "nccn",
      "source_id": "nccn-breast-1.2026-1770067616584",
      "evidence_type": "guideline",
      "is_superseded": false,
      "cancer_types": [],
      "clinical_settings": [],
      "questions": [],
      "classification": {
        "category": "decision_support",
        "decisionPoints": [],
        "cancerTypeStage": [],
        "testSpecific": []
      },
      "has_decision_context": true,
      "has_direct_quotes": true,
      "has_guardrail": false
    },
    {
      "id": 54,
      "title": "NCCN Breast Cancer: biomarker testing for targeted therapy selection",
      "source_type": "nccn",
      "source_id": "nccn-breast-1.2026-1770067616742",
      "evidence_type": "guideline",
      "is_superseded": false,
      "cancer_types": [],
      "clinical_settings": [],
      "questions": [],
      "classification": {
        "category": "decision_support",
        "decisionPoints": [],
        "cancerTypeStage": [],
        "testSpecific": []
      },
      "has_decision_context": true,
      "has_direct_quotes": true,
      "has_guardrail": false
    },
    {
      "id": 55,
      "title": "NCCN Breast Cancer: biomarker testing for metastatic disease",
      "source_type": "nccn",
      "source_id": "nccn-breast-1.2026-1770067617030",
      "evidence_type": "guideline",
      "is_superseded": false,
      "cancer_types": [],
      "clinical_settings": [],
      "questions": [],
      "classification": {
        "category": "decision_support",
        "decisionPoints": [],
        "cancerTypeStage": [],
        "testSpecific": []
      },
      "has_decision_context": true,
      "has_direct_quotes": true,
      "has_guardrail": false
    },
    {
      "id": 56,
      "title": "NCCN Colorectal Cancer: high-risk stage II colon cancer adjuvant therapy decision",
      "source_type": "nccn",
      "source_id": "nccn-colorectal-5.2025-1770067631624",
      "evidence_type": "guideline",
      "is_superseded": false,
      "cancer_types": [],
      "clinical_settings": [],
      "questions": [],
      "classification": {
        "category": "decision_support",
        "decisionPoints": [],
        "cancerTypeStage": [],
        "testSpecific": []
      },
      "has_decision_context": true,
      "has_direct_quotes": true,
      "has_guardrail": false
    },
    {
      "id": 57,
      "title": "NCCN Colorectal Cancer: adjuvant therapy decision-making",
      "source_type": "nccn",
      "source_id": "nccn-colorectal-5.2025-1770067631756",
      "evidence_type": "guideline",
      "is_superseded": false,
      "cancer_types": [],
      "clinical_settings": [],
      "questions": [],
      "classification": {
        "category": "decision_support",
        "decisionPoints": [],
        "cancerTypeStage": [],
        "testSpecific": []
      },
      "has_decision_context": true,
      "has_direct_quotes": true,
      "has_guardrail": false
    },
    {
      "id": 58,
      "title": "NCCN Colorectal Cancer: adjuvant therapy decision-making",
      "source_type": "nccn",
      "source_id": "nccn-colorectal-5.2025-1770067631894",
      "evidence_type": "guideline",
      "is_superseded": false,
      "cancer_types": [],
      "clinical_settings": [],
      "questions": [],
      "classification": {
        "category": "decision_support",
        "decisionPoints": [],
        "cancerTypeStage": [],
        "testSpecific": []
      },
      "has_decision_context": true,
      "has_direct_quotes": true,
      "has_guardrail": false
    },
    {
      "id": 59,
      "title": "NCCN Colorectal Cancer: post-surgical surveillance",
      "source_type": "nccn",
      "source_id": "nccn-colorectal-5.2025-1770067632044",
      "evidence_type": "guideline",
      "is_superseded": false,
      "cancer_types": [],
      "clinical_settings": [],
      "questions": [],
      "classification": {
        "category": "decision_support",
        "decisionPoints": [],
        "cancerTypeStage": [],
        "testSpecific": []
      },
      "has_decision_context": true,
      "has_direct_quotes": true,
      "has_guardrail": false
    },
    {
      "id": 60,
      "title": "NCCN Melanoma Cancer: research and validation studies",
      "source_type": "nccn",
      "source_id": "nccn-melanoma-2.2025-1770067640093",
      "evidence_type": "guideline",
      "is_superseded": false,
      "cancer_types": [],
      "clinical_settings": [],
      "questions": [],
      "classification": {
        "category": "decision_support",
        "decisionPoints": [],
        "cancerTypeStage": [],
        "testSpecific": []
      },
      "has_decision_context": true,
      "has_direct_quotes": true,
      "has_guardrail": false
    },
    {
      "id": 61,
      "title": "NCCN Gastric Cancer: metastatic or advanced disease when tissue unavailable",
      "source_type": "nccn",
      "source_id": "nccn-gastric-2.2026-1770067649602",
      "evidence_type": "guideline",
      "is_superseded": false,
      "cancer_types": [],
      "clinical_settings": [],
      "questions": [],
      "classification": {
        "category": "decision_support",
        "decisionPoints": [],
        "cancerTypeStage": [],
        "testSpecific": []
      },
      "has_decision_context": true,
      "has_direct_quotes": true,
      "has_guardrail": false
    },
    {
      "id": 62,
      "title": "NCCN Gastric Cancer: disease progression monitoring in advanced/metastatic disease",
      "source_type": "nccn",
      "source_id": "nccn-gastric-2.2026-1770067649766",
      "evidence_type": "guideline",
      "is_superseded": false,
      "cancer_types": [],
      "clinical_settings": [],
      "questions": [],
      "classification": {
        "category": "decision_support",
        "decisionPoints": [],
        "cancerTypeStage": [],
        "testSpecific": []
      },
      "has_decision_context": true,
      "has_direct_quotes": true,
      "has_guardrail": false
    },
    {
      "id": 63,
      "title": "NCCN Gastric Cancer: metastatic or advanced gastric cancer with limited tissue availability or inability to undergo traditional biopsy",
      "source_type": "nccn",
      "source_id": "nccn-gastric-2.2026-1770067660842",
      "evidence_type": "guideline",
      "is_superseded": false,
      "cancer_types": [],
      "clinical_settings": [],
      "questions": [],
      "classification": {
        "category": "decision_support",
        "decisionPoints": [],
        "cancerTypeStage": [],
        "testSpecific": []
      },
      "has_decision_context": true,
      "has_direct_quotes": true,
      "has_guardrail": false
    },
    {
      "id": 64,
      "title": "NCCN Gastric Cancer: genomic profiling for treatment selection",
      "source_type": "nccn",
      "source_id": "nccn-gastric-2.2026-1770067661072",
      "evidence_type": "guideline",
      "is_superseded": false,
      "cancer_types": [],
      "clinical_settings": [],
      "questions": [],
      "classification": {
        "category": "decision_support",
        "decisionPoints": [],
        "cancerTypeStage": [],
        "testSpecific": []
      },
      "has_decision_context": true,
      "has_direct_quotes": true,
      "has_guardrail": false
    },
    {
      "id": 65,
      "title": "NCCN Gastric Cancer: preoperative immunotherapy monitoring",
      "source_type": "nccn",
      "source_id": "nccn-gastric-2.2026-1770067661215",
      "evidence_type": "guideline",
      "is_superseded": false,
      "cancer_types": [],
      "clinical_settings": [],
      "questions": [],
      "classification": {
        "category": "decision_support",
        "decisionPoints": [],
        "cancerTypeStage": [],
        "testSpecific": []
      },
      "has_decision_context": true,
      "has_direct_quotes": true,
      "has_guardrail": false
    },
    {
      "id": 66,
      "title": "NCCN Lung nsclc Cancer: initial diagnosis",
      "source_type": "nccn",
      "source_id": "nccn-lung_nsclc-3.2026-1770067683019",
      "evidence_type": "guideline",
      "is_superseded": false,
      "cancer_types": [],
      "clinical_settings": [],
      "questions": [],
      "classification": {
        "category": "decision_support",
        "decisionPoints": [],
        "cancerTypeStage": [],
        "testSpecific": []
      },
      "has_decision_context": true,
      "has_direct_quotes": true,
      "has_guardrail": false
    },
    {
      "id": 67,
      "title": "NCCN Lung nsclc Cancer: early-stage disease (stages I-III)",
      "source_type": "nccn",
      "source_id": "nccn-lung_nsclc-3.2026-1770067683176",
      "evidence_type": "guideline",
      "is_superseded": false,
      "cancer_types": [],
      "clinical_settings": [],
      "questions": [],
      "classification": {
        "category": "decision_support",
        "decisionPoints": [],
        "cancerTypeStage": [],
        "testSpecific": []
      },
      "has_decision_context": true,
      "has_direct_quotes": true,
      "has_guardrail": false
    },
    {
      "id": 68,
      "title": "NCCN Lung nsclc Cancer: metastatic disease confined to thorax",
      "source_type": "nccn",
      "source_id": "nccn-lung_nsclc-3.2026-1770067683334",
      "evidence_type": "guideline",
      "is_superseded": false,
      "cancer_types": [],
      "clinical_settings": [],
      "questions": [],
      "classification": {
        "category": "decision_support",
        "decisionPoints": [],
        "cancerTypeStage": [],
        "testSpecific": []
      },
      "has_decision_context": true,
      "has_direct_quotes": true,
      "has_guardrail": false
    },
    {
      "id": 69,
      "title": "NCCN Lung nsclc Cancer: advanced/metastatic disease biomarker testing",
      "source_type": "nccn",
      "source_id": "nccn-lung_nsclc-3.2026-1770067683506",
      "evidence_type": "guideline",
      "is_superseded": false,
      "cancer_types": [],
      "clinical_settings": [],
      "questions": [],
      "classification": {
        "category": "decision_support",
        "decisionPoints": [],
        "cancerTypeStage": [],
        "testSpecific": []
      },
      "has_decision_context": true,
      "has_direct_quotes": true,
      "has_guardrail": false
    },
    {
      "id": 70,
      "title": "NCCN Ovarian Cancer: recurrence setting for molecular analysis",
      "source_type": "nccn",
      "source_id": "nccn-ovarian-3.2025-1770067688878",
      "evidence_type": "guideline",
      "is_superseded": false,
      "cancer_types": [],
      "clinical_settings": [],
      "questions": [],
      "classification": {
        "category": "decision_support",
        "decisionPoints": [],
        "cancerTypeStage": [],
        "testSpecific": []
      },
      "has_decision_context": true,
      "has_direct_quotes": true,
      "has_guardrail": false
    },
    {
      "id": 71,
      "title": "NCCN Colorectal Cancer: adjuvant therapy decision",
      "source_type": "nccn",
      "source_id": "nccn-colorectal-4.2025-1770067707124",
      "evidence_type": "guideline",
      "is_superseded": false,
      "cancer_types": [],
      "clinical_settings": [],
      "questions": [],
      "classification": {
        "category": "decision_support",
        "decisionPoints": [],
        "cancerTypeStage": [],
        "testSpecific": []
      },
      "has_decision_context": true,
      "has_direct_quotes": true,
      "has_guardrail": false
    },
    {
      "id": 72,
      "title": "NCCN Colorectal Cancer: treatment decision-making",
      "source_type": "nccn",
      "source_id": "nccn-colorectal-4.2025-1770067707315",
      "evidence_type": "guideline",
      "is_superseded": false,
      "cancer_types": [],
      "clinical_settings": [],
      "questions": [],
      "classification": {
        "category": "decision_support",
        "decisionPoints": [],
        "cancerTypeStage": [],
        "testSpecific": []
      },
      "has_decision_context": true,
      "has_direct_quotes": true,
      "has_guardrail": false
    },
    {
      "id": 73,
      "title": "NCCN Colorectal Cancer: nonoperative management decision",
      "source_type": "nccn",
      "source_id": "nccn-colorectal-4.2025-1770067707524",
      "evidence_type": "guideline",
      "is_superseded": false,
      "cancer_types": [],
      "clinical_settings": [],
      "questions": [],
      "classification": {
        "category": "decision_support",
        "decisionPoints": [],
        "cancerTypeStage": [],
        "testSpecific": []
      },
      "has_decision_context": true,
      "has_direct_quotes": true,
      "has_guardrail": false
    },
    {
      "id": 74,
      "title": "ASCO colorectal: Treatment decision when tissue-based testing unavailable",
      "source_type": "asco",
      "source_id": "asco-colorectal-1770067851631",
      "evidence_type": "guideline",
      "is_superseded": false,
      "cancer_types": [],
      "clinical_settings": [],
      "questions": [],
      "classification": {
        "category": "decision_support",
        "decisionPoints": [],
        "cancerTypeStage": [],
        "testSpecific": []
      },
      "has_decision_context": true,
      "has_direct_quotes": true,
      "has_guardrail": false
    },
    {
      "id": 75,
      "title": "ASCO colorectal: Treatment decision when tissue access limited",
      "source_type": "asco",
      "source_id": "asco-colorectal-1770067851907",
      "evidence_type": "guideline",
      "is_superseded": false,
      "cancer_types": [],
      "clinical_settings": [],
      "questions": [],
      "classification": {
        "category": "decision_support",
        "decisionPoints": [],
        "cancerTypeStage": [],
        "testSpecific": []
      },
      "has_decision_context": true,
      "has_direct_quotes": true,
      "has_guardrail": false
    },
    {
      "id": 76,
      "title": "ASCO colorectal: Treatment monitoring and resistance detection",
      "source_type": "asco",
      "source_id": "asco-colorectal-1770067852077",
      "evidence_type": "guideline",
      "is_superseded": false,
      "cancer_types": [],
      "clinical_settings": [],
      "questions": [],
      "classification": {
        "category": "decision_support",
        "decisionPoints": [],
        "cancerTypeStage": [],
        "testSpecific": []
      },
      "has_decision_context": true,
      "has_direct_quotes": true,
      "has_guardrail": false
    },
    {
      "id": 77,
      "title": "ASCO colorectal: Post-treatment surveillance for recurrence risk assessment",
      "source_type": "asco",
      "source_id": "asco-colorectal-1770067852232",
      "evidence_type": "guideline",
      "is_superseded": false,
      "cancer_types": [],
      "clinical_settings": [],
      "questions": [],
      "classification": {
        "category": "decision_support",
        "decisionPoints": [],
        "cancerTypeStage": [],
        "testSpecific": []
      },
      "has_decision_context": true,
      "has_direct_quotes": true,
      "has_guardrail": false
    },
    {
      "id": 78,
      "title": "ASCO colorectal: Somatic testing for biomarker-directed treatment decisions",
      "source_type": "asco",
      "source_id": "asco-colorectal-1770067861017",
      "evidence_type": "guideline",
      "is_superseded": false,
      "cancer_types": [],
      "clinical_settings": [],
      "questions": [],
      "classification": {
        "category": "decision_support",
        "decisionPoints": [],
        "cancerTypeStage": [],
        "testSpecific": []
      },
      "has_decision_context": true,
      "has_direct_quotes": true,
      "has_guardrail": false
    },
    {
      "id": 79,
      "title": "ASCO colorectal: Sequential testing during disease progression or treatment changes",
      "source_type": "asco",
      "source_id": "asco-colorectal-1770067861268",
      "evidence_type": "guideline",
      "is_superseded": false,
      "cancer_types": [],
      "clinical_settings": [],
      "questions": [],
      "classification": {
        "category": "decision_support",
        "decisionPoints": [],
        "cancerTypeStage": [],
        "testSpecific": []
      },
      "has_decision_context": true,
      "has_direct_quotes": true,
      "has_guardrail": false
    },
    {
      "id": 80,
      "title": "ASCO colorectal: adjuvant treatment decision",
      "source_type": "asco",
      "source_id": "asco-colorectal-1770067875146",
      "evidence_type": "guideline",
      "is_superseded": false,
      "cancer_types": [],
      "clinical_settings": [],
      "questions": [],
      "classification": {
        "category": "decision_support",
        "decisionPoints": [],
        "cancerTypeStage": [],
        "testSpecific": []
      },
      "has_decision_context": true,
      "has_direct_quotes": true,
      "has_guardrail": false
    },
    {
      "id": 81,
      "title": "ESMO colorectal: Treatment decision - molecular profiling for targeted therapy",
      "source_type": "esmo",
      "source_id": "esmo-colorectal-1770067897741",
      "evidence_type": "clinical_practice_guideline",
      "is_superseded": false,
      "cancer_types": [],
      "clinical_settings": [],
      "questions": [],
      "classification": {
        "category": "background",
        "decisionPoints": [],
        "cancerTypeStage": [],
        "testSpecific": []
      },
      "has_decision_context": true,
      "has_direct_quotes": true,
      "has_guardrail": false
    },
    {
      "id": 82,
      "title": "ESMO colorectal: Treatment decision - choice of molecular profiling method",
      "source_type": "esmo",
      "source_id": "esmo-colorectal-1770067897973",
      "evidence_type": "clinical_practice_guideline",
      "is_superseded": false,
      "cancer_types": [],
      "clinical_settings": [],
      "questions": [],
      "classification": {
        "category": "background",
        "decisionPoints": [],
        "cancerTypeStage": [],
        "testSpecific": []
      },
      "has_decision_context": true,
      "has_direct_quotes": true,
      "has_guardrail": false
    },
    {
      "id": 83,
      "title": "ESMO colorectal: Treatment decision - follow-up testing after negative ctDNA",
      "source_type": "esmo",
      "source_id": "esmo-colorectal-1770067898152",
      "evidence_type": "clinical_practice_guideline",
      "is_superseded": false,
      "cancer_types": [],
      "clinical_settings": [],
      "questions": [],
      "classification": {
        "category": "decision_support",
        "decisionPoints": [],
        "cancerTypeStage": [],
        "testSpecific": []
      },
      "has_decision_context": true,
      "has_direct_quotes": true,
      "has_guardrail": false
    },
    {
      "id": 84,
      "title": "ESMO colorectal: Surveillance - molecular residual disease detection",
      "source_type": "esmo",
      "source_id": "esmo-colorectal-1770067898346",
      "evidence_type": "clinical_practice_guideline",
      "is_superseded": false,
      "cancer_types": [],
      "clinical_settings": [],
      "questions": [],
      "classification": {
        "category": "background",
        "decisionPoints": [],
        "cancerTypeStage": [],
        "testSpecific": []
      },
      "has_decision_context": true,
      "has_direct_quotes": true,
      "has_guardrail": false
    },
    {
      "id": 85,
      "title": "ESMO colorectal: Surveillance - routine clinical practice",
      "source_type": "esmo",
      "source_id": "esmo-colorectal-1770067898506",
      "evidence_type": "clinical_practice_guideline",
      "is_superseded": false,
      "cancer_types": [],
      "clinical_settings": [],
      "questions": [],
      "classification": {
        "category": "background",
        "decisionPoints": [],
        "cancerTypeStage": [],
        "testSpecific": []
      },
      "has_decision_context": true,
      "has_direct_quotes": true,
      "has_guardrail": false
    },
    {
      "id": 86,
      "title": "ASCO colorectal: molecular testing for treatment selection",
      "source_type": "asco",
      "source_id": "asco-colorectal-1770067906972",
      "evidence_type": "guideline",
      "is_superseded": false,
      "cancer_types": [],
      "clinical_settings": [],
      "questions": [],
      "classification": {
        "category": "decision_support",
        "decisionPoints": [],
        "cancerTypeStage": [],
        "testSpecific": []
      },
      "has_decision_context": true,
      "has_direct_quotes": true,
      "has_guardrail": false
    },
    {
      "id": 87,
      "title": "ESMO breast: Post-operative surveillance/prognostication",
      "source_type": "esmo",
      "source_id": "esmo-breast-1770067927375",
      "evidence_type": "clinical_practice_guideline",
      "is_superseded": false,
      "cancer_types": [],
      "clinical_settings": [],
      "questions": [],
      "classification": {
        "category": "background",
        "decisionPoints": [],
        "cancerTypeStage": [],
        "testSpecific": []
      },
      "has_decision_context": true,
      "has_direct_quotes": true,
      "has_guardrail": false
    },
    {
      "id": 88,
      "title": "ESMO breast: Treatment de-escalation decisions",
      "source_type": "esmo",
      "source_id": "esmo-breast-1770067927510",
      "evidence_type": "clinical_practice_guideline",
      "is_superseded": false,
      "cancer_types": [],
      "clinical_settings": [],
      "questions": [],
      "classification": {
        "category": "background",
        "decisionPoints": [],
        "cancerTypeStage": [],
        "testSpecific": []
      },
      "has_decision_context": true,
      "has_direct_quotes": true,
      "has_guardrail": false
    },
    {
      "id": 89,
      "title": "ESMO breast: Neoadjuvant treatment/prognostication",
      "source_type": "esmo",
      "source_id": "esmo-breast-1770067927648",
      "evidence_type": "clinical_practice_guideline",
      "is_superseded": false,
      "cancer_types": [],
      "clinical_settings": [],
      "questions": [],
      "classification": {
        "category": "background",
        "decisionPoints": [],
        "cancerTypeStage": [],
        "testSpecific": []
      },
      "has_decision_context": true,
      "has_direct_quotes": true,
      "has_guardrail": false
    },
    {
      "id": 90,
      "title": "ESMO breast: Treatment response monitoring",
      "source_type": "esmo",
      "source_id": "esmo-breast-1770067927786",
      "evidence_type": "clinical_practice_guideline",
      "is_superseded": false,
      "cancer_types": [],
      "clinical_settings": [],
      "questions": [],
      "classification": {
        "category": "policy",
        "decisionPoints": [],
        "cancerTypeStage": [],
        "testSpecific": []
      },
      "has_decision_context": true,
      "has_direct_quotes": true,
      "has_guardrail": false
    },
    {
      "id": 91,
      "title": "ESMO breast: Treatment decision-making after curative treatment",
      "source_type": "esmo",
      "source_id": "esmo-breast-1770067927928",
      "evidence_type": "clinical_practice_guideline",
      "is_superseded": false,
      "cancer_types": [],
      "clinical_settings": [],
      "questions": [],
      "classification": {
        "category": "policy",
        "decisionPoints": [],
        "cancerTypeStage": [],
        "testSpecific": []
      },
      "has_decision_context": true,
      "has_direct_quotes": true,
      "has_guardrail": false
    },
    {
      "id": 92,
      "title": "SITC colorectal: Biomarker testing for treatment eligibility",
      "source_type": "sitc",
      "source_id": "sitc-colorectal-1770067953829",
      "evidence_type": "consensus_statement",
      "is_superseded": false,
      "cancer_types": [],
      "clinical_settings": [],
      "questions": [],
      "classification": {
        "category": "background",
        "decisionPoints": [],
        "cancerTypeStage": [],
        "testSpecific": []
      },
      "has_decision_context": true,
      "has_direct_quotes": true,
      "has_guardrail": false
    },
    {
      "id": 93,
      "title": "SITC colorectal: Early-phase immunotherapy clinical trials",
      "source_type": "sitc",
      "source_id": "sitc-colorectal-1770067953972",
      "evidence_type": "consensus_statement",
      "is_superseded": false,
      "cancer_types": [],
      "clinical_settings": [],
      "questions": [],
      "classification": {
        "category": "background",
        "decisionPoints": [],
        "cancerTypeStage": [],
        "testSpecific": []
      },
      "has_decision_context": true,
      "has_direct_quotes": true,
      "has_guardrail": false
    },
    {
      "id": 94,
      "title": "What's New Related to Drugs",
      "source_type": "fda",
      "source_id": "http://www.fda.gov/drugs/news-events-human-drugs/whats-new-related-drugs",
      "evidence_type": "regulatory",
      "is_superseded": false,
      "cancer_types": [],
      "clinical_settings": [],
      "questions": [],
      "classification": {
        "category": "policy",
        "decisionPoints": [],
        "cancerTypeStage": [],
        "testSpecific": []
      },
      "has_decision_context": false,
      "has_direct_quotes": false,
      "has_guardrail": false
    },
    {
      "id": 95,
      "title": "Pain and Arthritis Products Containing Hidden Ingredients",
      "source_type": "fda",
      "source_id": "fda-doc02h-d-arthritis-products-containing-hidden-ingredients",
      "evidence_type": "regulatory",
      "is_superseded": false,
      "cancer_types": [],
      "clinical_settings": [],
      "questions": [],
      "classification": {
        "category": "policy",
        "decisionPoints": [],
        "cancerTypeStage": [],
        "testSpecific": []
      },
      "has_decision_context": false,
      "has_direct_quotes": false,
      "has_guardrail": false
    },
    {
      "id": 96,
      "title": "Abbott Initiates Medical Device Correction for Certain FreeStyle Libre® 3 and FreeStyle Libre 3 Plus Sensors in the U.S.",
      "source_type": "fda",
      "source_id": "fda-kjszd1-tain-freestyle-librer-3-and-freestyle-libre-3-plus",
      "evidence_type": "regulatory",
      "is_superseded": false,
      "cancer_types": [],
      "clinical_settings": [],
      "questions": [],
      "classification": {
        "category": "policy",
        "decisionPoints": [],
        "cancerTypeStage": [],
        "testSpecific": []
      },
      "has_decision_context": false,
      "has_direct_quotes": false,
      "has_guardrail": false
    },
    {
      "id": 97,
      "title": "ctDNA-Guided Immunotherapy following Radical Cystectomy for Muscle-Invasive Bladder Cancer: Results from the TOMBOLA Trial",
      "source_type": "rss-esmo",
      "source_id": "annals_oncology-1770070270605",
      "evidence_type": "review",
      "is_superseded": false,
      "cancer_types": [],
      "clinical_settings": [],
      "questions": [],
      "classification": {
        "category": "background",
        "decisionPoints": [],
        "cancerTypeStage": [],
        "testSpecific": []
      },
      "has_decision_context": false,
      "has_direct_quotes": false,
      "has_guardrail": false
    },
    {
      "id": 98,
      "title": "Prospective Validation of  Circulating Tumor DNA Measurable Residual Disease After First-Line Therapy in Large B-Cell Lymphoma",
      "source_type": "rss-asco",
      "source_id": "jco-1770070289518",
      "evidence_type": "review",
      "is_superseded": false,
      "cancer_types": [],
      "clinical_settings": [],
      "questions": [],
      "classification": {
        "category": "background",
        "decisionPoints": [],
        "cancerTypeStage": [],
        "testSpecific": []
      },
      "has_decision_context": false,
      "has_direct_quotes": false,
      "has_guardrail": false
    },
    {
      "id": 99,
      "title": "Phased Variant–Supported Circulating Tumor DNA as a Prognostic Biomarker After First-Line Treatment in Large B-Cell Lymphoma: Findings From the DIRECT Study",
      "source_type": "rss-asco",
      "source_id": "jco-1770070289623",
      "evidence_type": "review",
      "is_superseded": false,
      "cancer_types": [],
      "clinical_settings": [],
      "questions": [],
      "classification": {
        "category": "background",
        "decisionPoints": [],
        "cancerTypeStage": [],
        "testSpecific": []
      },
      "has_decision_context": false,
      "has_direct_quotes": false,
      "has_guardrail": false
    },
    {
      "id": 100,
      "title": "Tissue-Free Circulating Tumor DNA Assay and Patient Outcome in a Phase III Trial of FOLFOX-Based Adjuvant Chemotherapy (Alliance N0147)",
      "source_type": "rss-asco",
      "source_id": "jco-1770070289812",
      "evidence_type": "review",
      "is_superseded": false,
      "cancer_types": [],
      "clinical_settings": [],
      "questions": [],
      "classification": {
        "category": "background",
        "decisionPoints": [],
        "cancerTypeStage": [],
        "testSpecific": []
      },
      "has_decision_context": false,
      "has_direct_quotes": false,
      "has_guardrail": false
    },
    {
      "id": 101,
      "title": "Precision Oncology 2.0: Guiding Magic Bullets With Expression-Based Liquid Biopsy",
      "source_type": "rss-asco",
      "source_id": "jco-1770070289942",
      "evidence_type": "review",
      "is_superseded": false,
      "cancer_types": [],
      "clinical_settings": [],
      "questions": [],
      "classification": {
        "category": "background",
        "decisionPoints": [],
        "cancerTypeStage": [],
        "testSpecific": []
      },
      "has_decision_context": false,
      "has_direct_quotes": false,
      "has_guardrail": false
    },
    {
      "id": 102,
      "title": "Spectrum of driver mutations and clinical impact of circulating tumor DNA analysis in non-small cell lung cancer: Analysis of over 8000 cases.",
      "source_type": "pubmed",
      "source_id": "32365229",
      "evidence_type": "observational",
      "is_superseded": false,
      "cancer_types": [
        "lung_nsclc"
      ],
      "clinical_settings": [
        "recurrence",
        "surveillance",
        "diagnosis"
      ],
      "questions": [],
      "classification": {
        "category": "background",
        "decisionPoints": [],
        "cancerTypeStage": [
          "lung_nsclc"
        ],
        "testSpecific": []
      },
      "has_decision_context": true,
      "has_direct_quotes": false,
      "has_guardrail": false
    },
    {
      "id": 103,
      "title": "Genomic Profiling of Circulating Tumor DNA Predicts Outcome and Demonstrates Tumor Evolution in ALK-Positive Non-Small Cell Lung Cancer Patients.",
      "source_type": "pubmed",
      "source_id": "32290439",
      "evidence_type": "observational",
      "is_superseded": false,
      "cancer_types": [
        "lung_nsclc"
      ],
      "clinical_settings": [
        "metastatic",
        "surveillance"
      ],
      "questions": [],
      "classification": {
        "category": "background",
        "decisionPoints": [],
        "cancerTypeStage": [
          "lung_nsclc"
        ],
        "testSpecific": []
      },
      "has_decision_context": true,
      "has_direct_quotes": false,
      "has_guardrail": false
    },
    {
      "id": 104,
      "title": "Prognostic Value of Circulating Tumor DNA (ctDNA) in Oncogene-Driven NSCLC: Current Knowledge and Future Perspectives.",
      "source_type": "pubmed",
      "source_id": "36230877",
      "evidence_type": "review",
      "is_superseded": false,
      "cancer_types": [
        "lung_nsclc"
      ],
      "clinical_settings": [
        "diagnosis",
        "recurrence",
        "surveillance"
      ],
      "questions": [],
      "classification": {
        "category": "background",
        "decisionPoints": [],
        "cancerTypeStage": [
          "lung_nsclc"
        ],
        "testSpecific": []
      },
      "has_decision_context": true,
      "has_direct_quotes": false,
      "has_guardrail": false
    },
    {
      "id": 105,
      "title": "DNA damage response as a prognostic indicator in metastatic breast cancer via mutational analysis.",
      "source_type": "pubmed",
      "source_id": "33708847",
      "evidence_type": "observational",
      "is_superseded": false,
      "cancer_types": [
        "breast"
      ],
      "clinical_settings": [
        "metastatic"
      ],
      "questions": [],
      "classification": {
        "category": "background",
        "decisionPoints": [],
        "cancerTypeStage": [
          "breast"
        ],
        "testSpecific": []
      },
      "has_decision_context": true,
      "has_direct_quotes": false,
      "has_guardrail": false
    },
    {
      "id": 106,
      "title": "Prospective Validation of  Circulating Tumor DNA Measurable Residual Disease After First-Line Therapy in Large B-Cell Lymphoma",
      "source_type": "rss-asco",
      "source_id": "jco-1770069485036",
      "evidence_type": "review",
      "is_superseded": false,
      "cancer_types": [],
      "clinical_settings": [],
      "questions": [],
      "classification": {
        "category": "background",
        "decisionPoints": [],
        "cancerTypeStage": [],
        "testSpecific": []
      },
      "has_decision_context": true,
      "has_direct_quotes": false,
      "has_guardrail": false
    },
    {
      "id": 107,
      "title": "Phased Variant–Supported Circulating Tumor DNA as a Prognostic Biomarker After First-Line Treatment in Large B-Cell Lymphoma: Findings From the DIRECT Study",
      "source_type": "rss-asco",
      "source_id": "jco-1770069485168",
      "evidence_type": "review",
      "is_superseded": false,
      "cancer_types": [],
      "clinical_settings": [],
      "questions": [],
      "classification": {
        "category": "background",
        "decisionPoints": [],
        "cancerTypeStage": [],
        "testSpecific": []
      },
      "has_decision_context": true,
      "has_direct_quotes": false,
      "has_guardrail": false
    },
    {
      "id": 108,
      "title": "Tissue-Free Circulating Tumor DNA Assay and Patient Outcome in a Phase III Trial of FOLFOX-Based Adjuvant Chemotherapy (Alliance N0147)",
      "source_type": "rss-asco",
      "source_id": "jco-1770069485262",
      "evidence_type": "review",
      "is_superseded": false,
      "cancer_types": [],
      "clinical_settings": [],
      "questions": [],
      "classification": {
        "category": "background",
        "decisionPoints": [],
        "cancerTypeStage": [],
        "testSpecific": []
      },
      "has_decision_context": true,
      "has_direct_quotes": false,
      "has_guardrail": false
    },
    {
      "id": 109,
      "title": "Precision Oncology 2.0: Guiding Magic Bullets With Expression-Based Liquid Biopsy",
      "source_type": "rss-asco",
      "source_id": "jco-1770069485380",
      "evidence_type": "review",
      "is_superseded": false,
      "cancer_types": [],
      "clinical_settings": [],
      "questions": [],
      "classification": {
        "category": "background",
        "decisionPoints": [],
        "cancerTypeStage": [],
        "testSpecific": []
      },
      "has_decision_context": true,
      "has_direct_quotes": false,
      "has_guardrail": false
    },
    {
      "id": 110,
      "title": "ctDNA-Guided Immunotherapy following Radical Cystectomy for Muscle-Invasive Bladder Cancer: Results from the TOMBOLA Trial",
      "source_type": "rss-esmo",
      "source_id": "annals_oncology-1770069486735",
      "evidence_type": "review",
      "is_superseded": false,
      "cancer_types": [],
      "clinical_settings": [],
      "questions": [],
      "classification": {
        "category": "background",
        "decisionPoints": [],
        "cancerTypeStage": [],
        "testSpecific": []
      },
      "has_decision_context": true,
      "has_direct_quotes": false,
      "has_guardrail": false
    },
    {
      "id": 111,
      "title": "Circulating tumor DNA using a plasma-only assay predicts survival in patients with oligometastatic colorectal cancer after definitive therapy.",
      "source_type": "pubmed",
      "source_id": "40386606",
      "evidence_type": "rct_results",
      "is_superseded": false,
      "cancer_types": [
        "colorectal"
      ],
      "clinical_settings": [],
      "questions": [],
      "classification": {
        "category": "background",
        "decisionPoints": [],
        "cancerTypeStage": [
          "colorectal"
        ],
        "testSpecific": [
          "Guardant Reveal"
        ]
      },
      "has_decision_context": true,
      "has_direct_quotes": false,
      "has_guardrail": false
    },
    {
      "id": 112,
      "title": "Clinical performance of tumor-informed versus tumor-agnostic ctDNA assays for colorectal cancer recurrence: A systematic review and diagnostic accuracy meta-analysis.",
      "source_type": "pubmed",
      "source_id": "41401645",
      "evidence_type": "rct_results",
      "is_superseded": false,
      "cancer_types": [
        "multi_solid"
      ],
      "clinical_settings": [],
      "questions": [],
      "classification": {
        "category": "background",
        "decisionPoints": [],
        "cancerTypeStage": [
          "multi_solid"
        ],
        "testSpecific": []
      },
      "has_decision_context": true,
      "has_direct_quotes": false,
      "has_guardrail": false
    },
    {
      "id": 113,
      "title": "Circulating tumor DNA level is associated with time to clinical recurrence in Merkel cell carcinoma: Implications for patient management.",
      "source_type": "pubmed",
      "source_id": "41077138",
      "evidence_type": "rct_results",
      "is_superseded": false,
      "cancer_types": [
        "multi_solid"
      ],
      "clinical_settings": [],
      "questions": [],
      "classification": {
        "category": "background",
        "decisionPoints": [],
        "cancerTypeStage": [
          "multi_solid_stage_I"
        ],
        "testSpecific": []
      },
      "has_decision_context": true,
      "has_direct_quotes": false,
      "has_guardrail": false
    },
    {
      "id": 114,
      "title": "ctDNA dynamics and recurrence patterns after organ-sparing trimodality therapy for bladder cancer.",
      "source_type": "pubmed",
      "source_id": "41587110",
      "evidence_type": "rct_results",
      "is_superseded": false,
      "cancer_types": [
        "multi_solid"
      ],
      "clinical_settings": [],
      "questions": [],
      "classification": {
        "category": "background",
        "decisionPoints": [],
        "cancerTypeStage": [
          "multi_solid"
        ],
        "testSpecific": [
          "Signatera",
          "Natera"
        ]
      },
      "has_decision_context": true,
      "has_direct_quotes": false,
      "has_guardrail": false
    },
    {
      "id": 118,
      "title": "Circulating Tumor DNA Analysis Guiding Adjuvant Therapy in Stage II Colon Cancer (DYNAMIC)",
      "source_type": "seed_publication",
      "source_id": "10_1056_NEJMoa2200075",
      "evidence_type": "rct_results",
      "is_superseded": false,
      "cancer_types": [
        "colorectal",
        "multi_solid"
      ],
      "clinical_settings": [
        "recurrence_detection",
        "surveillance",
        "adjuvant"
      ],
      "questions": [],
      "classification": {
        "category": "background",
        "decisionPoints": [],
        "cancerTypeStage": [
          "colorectal_stage_II",
          "multi_solid_stage_II"
        ],
        "testSpecific": [
          "Signatera",
          "Natera"
        ]
      },
      "has_decision_context": true,
      "has_direct_quotes": false,
      "has_guardrail": false
    },
    {
      "id": 119,
      "title": "Molecular recurrence after surgical resection in patients with cancer: a prospective observational study",
      "source_type": "seed_publication",
      "source_id": "seed_molecular_recurrence_after_surgical_resection_in_p_unknown",
      "evidence_type": "observational",
      "is_superseded": false,
      "cancer_types": [
        "multi_solid"
      ],
      "clinical_settings": [],
      "questions": [],
      "classification": {
        "category": "background",
        "decisionPoints": [],
        "cancerTypeStage": [
          "multi_solid"
        ],
        "testSpecific": [
          "Signatera",
          "Natera"
        ]
      },
      "has_decision_context": true,
      "has_direct_quotes": false,
      "has_guardrail": false
    },
    {
      "id": 120,
      "title": "Use of circulating tumor DNA for detection of molecular residual disease and prediction of recurrence in Merkel cell carcinoma",
      "source_type": "seed_publication",
      "source_id": "seed_use_of_circulating_tumor_dna_for_detection_of_mole_unknown",
      "evidence_type": "observational",
      "is_superseded": false,
      "cancer_types": [
        "merkel_cell"
      ],
      "clinical_settings": [],
      "questions": [],
      "classification": {
        "category": "background",
        "decisionPoints": [],
        "cancerTypeStage": [
          "merkel_cell"
        ],
        "testSpecific": [
          "Signatera",
          "Natera"
        ]
      },
      "has_decision_context": true,
      "has_direct_quotes": false,
      "has_guardrail": false
    },
    {
      "id": 121,
      "title": "Circulating tumor DNA in stage III colorectal cancer, a post-hoc analysis of the IMBLZE370 trial",
      "source_type": "seed_publication",
      "source_id": "seed_circulating_tumor_dna_in_stage_iii_colorectal_canc_unknown",
      "evidence_type": "observational",
      "is_superseded": false,
      "cancer_types": [
        "colorectal"
      ],
      "clinical_settings": [],
      "questions": [],
      "classification": {
        "category": "background",
        "decisionPoints": [],
        "cancerTypeStage": [
          "colorectal_stage_III"
        ],
        "testSpecific": [
          "Signatera",
          "Natera"
        ]
      },
      "has_decision_context": true,
      "has_direct_quotes": false,
      "has_guardrail": false
    },
    {
      "id": 122,
      "title": "Colorectal Cancer Recurrence Prediction Using a Tissue-Free Epigenomic Minimal Residual Disease Assay",
      "source_type": "seed_publication",
      "source_id": "seed_colorectal_cancer_recurrence_prediction_using_a_ti_2021",
      "evidence_type": "observational",
      "is_superseded": false,
      "cancer_types": [
        "colorectal"
      ],
      "clinical_settings": [],
      "questions": [],
      "classification": {
        "category": "background",
        "decisionPoints": [],
        "cancerTypeStage": [
          "colorectal"
        ],
        "testSpecific": []
      },
      "has_decision_context": true,
      "has_direct_quotes": false,
      "has_guardrail": false
    },
    {
      "id": 123,
      "title": "Minimal Residual Disease Detection Using a Plasma-Only Circulating Tumor DNA Assay in Colorectal Cancer Patients",
      "source_type": "seed_publication",
      "source_id": "10_1158_1078_0432_CCR_21_1567",
      "evidence_type": "observational",
      "is_superseded": false,
      "cancer_types": [
        "colorectal"
      ],
      "clinical_settings": [],
      "questions": [],
      "classification": {
        "category": "background",
        "decisionPoints": [],
        "cancerTypeStage": [
          "colorectal"
        ],
        "testSpecific": []
      },
      "has_decision_context": true,
      "has_direct_quotes": false,
      "has_guardrail": false
    },
    {
      "id": 124,
      "title": "A Tumor-Naïve ctDNA Assay Detects Minimal Residual Disease in Resected Stage II or III Colorectal Cancer and Predicts Recurrence: Subset Analysis From the GALAXY Study in CIRCULATE-Japan",
      "source_type": "pubmed",
      "source_id": "39513962",
      "evidence_type": "rct_results",
      "is_superseded": false,
      "cancer_types": [
        "colorectal"
      ],
      "clinical_settings": [],
      "questions": [],
      "classification": {
        "category": "background",
        "decisionPoints": [],
        "cancerTypeStage": [
          "colorectal_stage_II"
        ],
        "testSpecific": []
      },
      "has_decision_context": true,
      "has_direct_quotes": false,
      "has_guardrail": false
    },
    {
      "id": 125,
      "title": "Residual ctDNA after treatment predicts early relapse in patients with early-stage non-small cell lung cancer",
      "source_type": "pubmed",
      "source_id": "35306155",
      "evidence_type": "observational",
      "is_superseded": false,
      "cancer_types": [
        "lung_nsclc"
      ],
      "clinical_settings": [],
      "questions": [],
      "classification": {
        "category": "background",
        "decisionPoints": [],
        "cancerTypeStage": [
          "lung_nsclc_stage_I"
        ],
        "testSpecific": [
          "RaDaR"
        ]
      },
      "has_decision_context": true,
      "has_direct_quotes": false,
      "has_guardrail": false
    },
    {
      "id": 126,
      "title": "A personalised circulating tumour DNA analysis in head and neck squamous-cell carcinoma: a prospective study",
      "source_type": "pubmed",
      "source_id": "35132238",
      "evidence_type": "observational",
      "is_superseded": false,
      "cancer_types": [
        "head_neck"
      ],
      "clinical_settings": [],
      "questions": [],
      "classification": {
        "category": "background",
        "decisionPoints": [],
        "cancerTypeStage": [
          "head_neck"
        ],
        "testSpecific": [
          "RaDaR"
        ]
      },
      "has_decision_context": true,
      "has_direct_quotes": false,
      "has_guardrail": false
    },
    {
      "id": 127,
      "title": "NCCN Guidelines® for Multiple Myeloma (referenced excerpt showing MRD assessment timepoints)",
      "source_type": "guideline",
      "source_id": "seed_nccn_guidelines_for_multiple_myeloma_referenced_ex_2021",
      "evidence_type": "guideline",
      "is_superseded": false,
      "cancer_types": [
        "multi_solid",
        "multiple_myeloma"
      ],
      "clinical_settings": [],
      "questions": [],
      "classification": {
        "category": "decision_support",
        "decisionPoints": [],
        "cancerTypeStage": [
          "multi_solid",
          "multiple_myeloma"
        ],
        "testSpecific": [
          "clonoSEQ"
        ]
      },
      "has_decision_context": true,
      "has_direct_quotes": false,
      "has_guardrail": false
    },
    {
      "id": 128,
      "title": "NCCN Guidelines® for Adult & AYA Patients with ALL (referenced excerpt showing MRD monitoring guidance)",
      "source_type": "guideline",
      "source_id": "seed_nccn_guidelines_for_adult_aya_patients_with_all_re_2021",
      "evidence_type": "guideline",
      "is_superseded": false,
      "cancer_types": [
        "all"
      ],
      "clinical_settings": [],
      "questions": [],
      "classification": {
        "category": "decision_support",
        "decisionPoints": [],
        "cancerTypeStage": [
          "all"
        ],
        "testSpecific": [
          "clonoSEQ"
        ]
      },
      "has_decision_context": true,
      "has_direct_quotes": false,
      "has_guardrail": false
    },
    {
      "id": 129,
      "title": "FDA 510(k) Review Summary for clonoSEQ (K200009)",
      "source_type": "regulatory",
      "source_id": "seed_fda_510_k_review_summary_for_clonoseq_k200009__2020",
      "evidence_type": "regulatory",
      "is_superseded": false,
      "cancer_types": [
        "all",
        "cll",
        "multi_solid",
        "multiple_myeloma"
      ],
      "clinical_settings": [],
      "questions": [],
      "classification": {
        "category": "policy",
        "decisionPoints": [],
        "cancerTypeStage": [
          "all",
          "cll",
          "multi_solid",
          "multiple_myeloma"
        ],
        "testSpecific": [
          "clonoSEQ"
        ]
      },
      "has_decision_context": true,
      "has_direct_quotes": false,
      "has_guardrail": false
    },
    {
      "id": 130,
      "title": "NCCN updates ctDNA stipulations in colon, rectal, and Merkel cell carcinoma guidelines (public summary)",
      "source_type": "seed_publication",
      "source_id": "seed_nccn_updates_ctdna_stipulations_in_colon_rectal_an_2025",
      "evidence_type": "review",
      "is_superseded": false,
      "cancer_types": [
        "colorectal",
        "merkel_cell"
      ],
      "clinical_settings": [],
      "questions": [],
      "classification": {
        "category": "background",
        "decisionPoints": [],
        "cancerTypeStage": [
          "colorectal",
          "merkel_cell"
        ],
        "testSpecific": []
      },
      "has_decision_context": true,
      "has_direct_quotes": false,
      "has_guardrail": false
    },
    {
      "id": 131,
      "title": "Circulating tumour DNA in colorectal cancer: guiding treatment and research (society editorial)",
      "source_type": "seed_publication",
      "source_id": "seed_circulating_tumour_dna_in_colorectal_cancer_guidin_2025",
      "evidence_type": "consensus",
      "is_superseded": false,
      "cancer_types": [
        "colorectal"
      ],
      "clinical_settings": [],
      "questions": [],
      "classification": {
        "category": "decision_support",
        "decisionPoints": [],
        "cancerTypeStage": [
          "colorectal"
        ],
        "testSpecific": []
      },
      "has_decision_context": true,
      "has_direct_quotes": false,
      "has_guardrail": false
    },
    {
      "id": 132,
      "title": "Addition of Durvalumab to BCG After TURBT for BCG-Naive, High-Risk NMIBC",
      "source_type": "extracted_publication",
      "source_id": "ext-1770155644367-7pqdzv",
      "evidence_type": "rct_results",
      "is_superseded": false,
      "cancer_types": [
        "bladder"
      ],
      "clinical_settings": [],
      "questions": [],
      "classification": {
        "category": "background",
        "decisionPoints": [],
        "cancerTypeStage": [
          "bladder"
        ],
        "testSpecific": []
      },
      "has_decision_context": true,
      "has_direct_quotes": false,
      "has_guardrail": false
    },
    {
      "id": 133,
      "title": "Intensity-Modulated Proton vs Photon Radiotherapy in Oropharyngeal Cancer",
      "source_type": "pubmed",
      "source_id": "41391462",
      "evidence_type": "rct_results",
      "is_superseded": false,
      "cancer_types": [
        "multi_solid"
      ],
      "clinical_settings": [],
      "questions": [],
      "classification": {
        "category": "background",
        "decisionPoints": [],
        "cancerTypeStage": [
          "multi_solid_stage_III"
        ],
        "testSpecific": []
      },
      "has_decision_context": true,
      "has_direct_quotes": false,
      "has_guardrail": false
    },
    {
      "id": 134,
      "title": "Global Cancer Survival Gaps Assessed Using a Country-Level Machine-Learning Framework",
      "source_type": "extracted_publication",
      "source_id": "ext-1770155645976-iyu82b",
      "evidence_type": "observational",
      "is_superseded": false,
      "cancer_types": [],
      "clinical_settings": [],
      "questions": [],
      "classification": {
        "category": "background",
        "decisionPoints": [],
        "cancerTypeStage": [],
        "testSpecific": []
      },
      "has_decision_context": true,
      "has_direct_quotes": false,
      "has_guardrail": false
    },
    {
      "id": 135,
      "title": "Circulating tumor DNA analysis detects minimal residual disease and predicts recurrence in patients with stage II colon cancer.",
      "source_type": "pubmed",
      "source_id": "27384348",
      "evidence_type": "observational",
      "is_superseded": false,
      "cancer_types": [
        "multi_solid"
      ],
      "clinical_settings": [],
      "questions": [],
      "classification": {
        "category": "background",
        "decisionPoints": [],
        "cancerTypeStage": [
          "multi_solid_stage_II"
        ],
        "testSpecific": []
      },
      "has_decision_context": true,
      "has_direct_quotes": false,
      "has_guardrail": false
    },
    {
      "id": 141,
      "title": "Diagnosis, treatment, and surveillance of Diamond-Blackfan anaemia syndrome: international consensus statement.",
      "source_type": "pubmed",
      "source_id": "38697731",
      "evidence_type": "rct_results",
      "is_superseded": false,
      "cancer_types": [
        "multi_solid"
      ],
      "clinical_settings": [],
      "questions": [],
      "classification": {
        "category": "decision_support",
        "decisionPoints": [],
        "cancerTypeStage": [
          "multi_solid"
        ],
        "testSpecific": []
      },
      "has_decision_context": true,
      "has_direct_quotes": false,
      "has_guardrail": false
    },
    {
      "id": 142,
      "title": "Impact of hematologic malignancy and type of cancer therapy on COVID-19 severity and mortality: lessons from a large population-based registry study.",
      "source_type": "pubmed",
      "source_id": "33032660",
      "evidence_type": "observational",
      "is_superseded": false,
      "cancer_types": [
        "multi_solid"
      ],
      "clinical_settings": [],
      "questions": [],
      "classification": {
        "category": "background",
        "decisionPoints": [],
        "cancerTypeStage": [
          "multi_solid"
        ],
        "testSpecific": []
      },
      "has_decision_context": true,
      "has_direct_quotes": false,
      "has_guardrail": false
    },
    {
      "id": 143,
      "title": "Daratumumab, Bortezomib, Lenalidomide, and Dexamethasone for Multiple Myeloma.",
      "source_type": "pubmed",
      "source_id": "38084760",
      "evidence_type": "rct_results",
      "is_superseded": false,
      "cancer_types": [
        "multi_solid"
      ],
      "clinical_settings": [],
      "questions": [],
      "classification": {
        "category": "background",
        "decisionPoints": [],
        "cancerTypeStage": [
          "multi_solid"
        ],
        "testSpecific": [
          "clonoSEQ"
        ]
      },
      "has_decision_context": true,
      "has_direct_quotes": false,
      "has_guardrail": false
    },
    {
      "id": 144,
      "title": "Two Phase 3 Trials of Inclisiran in Patients with Elevated LDL Cholesterol.",
      "source_type": "pubmed",
      "source_id": "32187462",
      "evidence_type": "rct_results",
      "is_superseded": false,
      "cancer_types": [
        "multi_solid"
      ],
      "clinical_settings": [],
      "questions": [],
      "classification": {
        "category": "background",
        "decisionPoints": [],
        "cancerTypeStage": [
          "multi_solid"
        ],
        "testSpecific": []
      },
      "has_decision_context": true,
      "has_direct_quotes": false,
      "has_guardrail": false
    },
    {
      "id": 145,
      "title": "Efficacy and safety of teclistamab in patients with relapsed/refractory multiple myeloma after BCMA-targeting therapies.",
      "source_type": "pubmed",
      "source_id": "39172760",
      "evidence_type": "observational",
      "is_superseded": false,
      "cancer_types": [
        "multi_solid"
      ],
      "clinical_settings": [],
      "questions": [],
      "classification": {
        "category": "background",
        "decisionPoints": [],
        "cancerTypeStage": [
          "multi_solid"
        ],
        "testSpecific": [
          "clonoSEQ"
        ]
      },
      "has_decision_context": true,
      "has_direct_quotes": false,
      "has_guardrail": false
    },
    {
      "id": 146,
      "title": "Toxicity and efficacy of CAR T-cell therapy in primary and secondary CNS lymphoma: a meta-analysis of 128 patients.",
      "source_type": "pubmed",
      "source_id": "36260735",
      "evidence_type": "meta_analysis",
      "is_superseded": false,
      "cancer_types": [
        "multi_solid"
      ],
      "clinical_settings": [],
      "questions": [],
      "classification": {
        "category": "background",
        "decisionPoints": [],
        "cancerTypeStage": [
          "multi_solid"
        ],
        "testSpecific": []
      },
      "has_decision_context": true,
      "has_direct_quotes": false,
      "has_guardrail": false
    },
    {
      "id": 147,
      "title": "Daratumumab, Carfilzomib, Lenalidomide, and Dexamethasone With Minimal Residual Disease Response-Adapted Therapy in Newly Diagnosed Multiple Myeloma.",
      "source_type": "pubmed",
      "source_id": "34898239",
      "evidence_type": "observational",
      "is_superseded": false,
      "cancer_types": [
        "multi_solid"
      ],
      "clinical_settings": [],
      "questions": [],
      "classification": {
        "category": "background",
        "decisionPoints": [],
        "cancerTypeStage": [
          "multi_solid"
        ],
        "testSpecific": []
      },
      "has_decision_context": true,
      "has_direct_quotes": false,
      "has_guardrail": false
    },
    {
      "id": 149,
      "title": "Identification of novel mutational drivers reveals oncogene dependencies in multiple myeloma.",
      "source_type": "pubmed",
      "source_id": "29884741",
      "evidence_type": "observational",
      "is_superseded": false,
      "cancer_types": [
        "multi_solid"
      ],
      "clinical_settings": [],
      "questions": [],
      "classification": {
        "category": "background",
        "decisionPoints": [],
        "cancerTypeStage": [
          "multi_solid"
        ],
        "testSpecific": []
      },
      "has_decision_context": true,
      "has_direct_quotes": false,
      "has_guardrail": false
    },
    {
      "id": 150,
      "title": "Treating Multiple Myeloma Patients With Oral Therapies.",
      "source_type": "pubmed",
      "source_id": "28347676",
      "evidence_type": "observational",
      "is_superseded": false,
      "cancer_types": [
        "multi_solid"
      ],
      "clinical_settings": [],
      "questions": [],
      "classification": {
        "category": "background",
        "decisionPoints": [],
        "cancerTypeStage": [
          "multi_solid"
        ],
        "testSpecific": []
      },
      "has_decision_context": true,
      "has_direct_quotes": false,
      "has_guardrail": false
    },
    {
      "id": 151,
      "title": "NCCN Clinical Practice Guidelines in Oncology: Multiple Myeloma V.2.2024",
      "source_type": "extracted_publication",
      "source_id": "ext-1770163522954-yteaa2",
      "evidence_type": "guideline",
      "is_superseded": false,
      "cancer_types": [
        "multi_solid"
      ],
      "clinical_settings": [],
      "questions": [],
      "classification": {
        "category": "decision_support",
        "decisionPoints": [],
        "cancerTypeStage": [
          "multi_solid"
        ],
        "testSpecific": []
      },
      "has_decision_context": true,
      "has_direct_quotes": false,
      "has_guardrail": false
    },
    {
      "id": 152,
      "title": "Measurement of ctDNA Tumor Fraction Identifies Informative Negative Liquid Biopsy Results and Informs Value of Tissue Confirmation.",
      "source_type": "pubmed",
      "source_id": "38526394",
      "evidence_type": "observational",
      "is_superseded": false,
      "cancer_types": [
        "multi_solid"
      ],
      "clinical_settings": [],
      "questions": [],
      "classification": {
        "category": "background",
        "decisionPoints": [],
        "cancerTypeStage": [
          "multi_solid"
        ],
        "testSpecific": []
      },
      "has_decision_context": true,
      "has_direct_quotes": false,
      "has_guardrail": false
    },
    {
      "id": 159,
      "title": "Circulating Tumor DNA as a Marker of Recurrence Risk in Stage III Colorectal Cancer: The &#x3b1;-CORRECT Study.",
      "source_type": "pubmed",
      "source_id": "39865324",
      "evidence_type": "observational",
      "is_superseded": false,
      "cancer_types": [
        "colorectal"
      ],
      "clinical_settings": [],
      "questions": [],
      "classification": {
        "category": "background",
        "decisionPoints": [],
        "cancerTypeStage": [
          "colorectal_stage_III"
        ],
        "testSpecific": []
      },
      "has_decision_context": true,
      "has_direct_quotes": false,
      "has_guardrail": false
    },
    {
      "id": 160,
      "title": "Therapy for Stage IV Non–Small Cell Lung Cancer With Driver Alterations: ASCO Living Guideline, 2026.3.0",
      "source_type": "pubmed",
      "source_id": "40014839",
      "evidence_type": "guideline",
      "is_superseded": false,
      "cancer_types": [
        "lung_nsclc"
      ],
      "clinical_settings": [],
      "questions": [],
      "classification": {
        "category": "decision_support",
        "decisionPoints": [],
        "cancerTypeStage": [
          "lung_nsclc_stage_IV"
        ],
        "testSpecific": []
      },
      "has_decision_context": true,
      "has_direct_quotes": false,
      "has_guardrail": false
    },
    {
      "id": 161,
      "title": "Therapy for Stage IV Non–Small Cell Lung Cancer Without Driver Alterations: ASCO Living Guideline, 2026.3.0",
      "source_type": "pubmed",
      "source_id": "40674687",
      "evidence_type": "guideline",
      "is_superseded": false,
      "cancer_types": [
        "lung_nsclc"
      ],
      "clinical_settings": [],
      "questions": [],
      "classification": {
        "category": "decision_support",
        "decisionPoints": [],
        "cancerTypeStage": [
          "lung_nsclc_stage_IV"
        ],
        "testSpecific": []
      },
      "has_decision_context": true,
      "has_direct_quotes": false,
      "has_guardrail": false
    },
    {
      "id": 162,
      "title": "Randomized Phase II/III Trial Comparing Hepatectomy, Followed by mFOLFOX6 With Hepatectomy Alone for Liver Metastasis From Colorectal Cancer: Long-Term Results of JCOG0603",
      "source_type": "pubmed",
      "source_id": "19389795",
      "evidence_type": "rct_results",
      "is_superseded": false,
      "cancer_types": [
        "colorectal"
      ],
      "clinical_settings": [],
      "questions": [],
      "classification": {
        "category": "background",
        "decisionPoints": [],
        "cancerTypeStage": [
          "colorectal"
        ],
        "testSpecific": []
      },
      "has_decision_context": true,
      "has_direct_quotes": false,
      "has_guardrail": false
    },
    {
      "id": 163,
      "title": "Tissue-Free Circulating Tumor DNA Assay and Patient Outcome in a Phase III Trial of FOLFOX-Based Adjuvant Chemotherapy (Alliance N0147)",
      "source_type": "pubmed",
      "source_id": "41616224",
      "evidence_type": "rct_results",
      "is_superseded": false,
      "cancer_types": [
        "colorectal"
      ],
      "clinical_settings": [],
      "questions": [],
      "classification": {
        "category": "background",
        "decisionPoints": [],
        "cancerTypeStage": [
          "colorectal"
        ],
        "testSpecific": []
      },
      "has_decision_context": true,
      "has_direct_quotes": false,
      "has_guardrail": false
    },
    {
      "id": 164,
      "title": "Postmastectomy Radiation Therapy: An ASTRO-ASCO-SSO Clinical Practice Guideline",
      "source_type": "pubmed",
      "source_id": "40955654",
      "evidence_type": "guideline",
      "is_superseded": false,
      "cancer_types": [
        "breast"
      ],
      "clinical_settings": [],
      "questions": [],
      "classification": {
        "category": "decision_support",
        "decisionPoints": [],
        "cancerTypeStage": [
          "breast"
        ],
        "testSpecific": []
      },
      "has_decision_context": true,
      "has_direct_quotes": false,
      "has_guardrail": false
    },
    {
      "id": 165,
      "title": "Sentinel Lymph Node Biopsy in Early-Stage Breast Cancer: ASCO Guideline Update",
      "source_type": "pubmed",
      "source_id": "40209128",
      "evidence_type": "guideline",
      "is_superseded": false,
      "cancer_types": [
        "breast"
      ],
      "clinical_settings": [],
      "questions": [],
      "classification": {
        "category": "decision_support",
        "decisionPoints": [],
        "cancerTypeStage": [
          "breast"
        ],
        "testSpecific": []
      },
      "has_decision_context": true,
      "has_direct_quotes": false,
      "has_guardrail": false
    },
    {
      "id": 166,
      "title": "Efficacy and Safety of Trastuzumab Deruxtecan in Patients With HER2-Expressing Solid Tumors: Primary Results From the DESTINY-PanTumor02 Phase II Trial",
      "source_type": "pubmed",
      "source_id": "37870536",
      "evidence_type": "rct_results",
      "is_superseded": false,
      "cancer_types": [
        "breast",
        "colorectal",
        "gastric"
      ],
      "clinical_settings": [],
      "questions": [],
      "classification": {
        "category": "background",
        "decisionPoints": [],
        "cancerTypeStage": [
          "breast",
          "colorectal",
          "gastric"
        ],
        "testSpecific": []
      },
      "has_decision_context": true,
      "has_direct_quotes": false,
      "has_guardrail": false
    },
    {
      "id": 167,
      "title": "A tumor-uninformed ctDNA assay detecting MRD in patients with resected stage II or III colorectal cancer predicts recurrence: Subset analysis from the GALAXY study in CIRCULATE-Japan",
      "source_type": "extracted_publication",
      "source_id": "ext-1770163690447-3f5wlt",
      "evidence_type": "observational",
      "is_superseded": false,
      "cancer_types": [
        "colorectal"
      ],
      "clinical_settings": [],
      "questions": [],
      "classification": {
        "category": "data_point",
        "decisionPoints": [],
        "cancerTypeStage": [
          "colorectal_stage_II"
        ],
        "testSpecific": []
      },
      "has_decision_context": true,
      "has_direct_quotes": false,
      "has_guardrail": false
    },
    {
      "id": 168,
      "title": "Overall survival in patients with endometrial cancer treated with dostarlimab plus carboplatin-paclitaxel in the randomized ENGOT-EN6/GOG-3031/RUBY trial.",
      "source_type": "pubmed",
      "source_id": "38866180",
      "evidence_type": "observational",
      "is_superseded": false,
      "cancer_types": [
        "lung_nsclc"
      ],
      "clinical_settings": [],
      "questions": [],
      "classification": {
        "category": "background",
        "decisionPoints": [],
        "cancerTypeStage": [
          "lung_nsclc"
        ],
        "testSpecific": []
      },
      "has_decision_context": true,
      "has_direct_quotes": false,
      "has_guardrail": false
    },
    {
      "id": 169,
      "title": "Ultra-sensitive ctDNA mutation tracking to identify molecular residual disease and predict relapse in early breast cancer patients",
      "source_type": "extracted_publication",
      "source_id": "ext-1770163692845-01ouy0",
      "evidence_type": "observational",
      "is_superseded": false,
      "cancer_types": [
        "breast"
      ],
      "clinical_settings": [],
      "questions": [],
      "classification": {
        "category": "background",
        "decisionPoints": [],
        "cancerTypeStage": [
          "breast"
        ],
        "testSpecific": []
      },
      "has_decision_context": true,
      "has_direct_quotes": false,
      "has_guardrail": false
    },
    {
      "id": 170,
      "title": "A Tumor-Naive ctDNA Assay Detects Minimal Residual Disease in Resected Stage II or III Colorectal Cancer and Predicts Recurrence: Subset Analysis From the GALAXY Study in CIRCULATE-Japan",
      "source_type": "extracted_publication",
      "source_id": "ext-1770163707890-aj8wds",
      "evidence_type": "observational",
      "is_superseded": false,
      "cancer_types": [
        "colorectal"
      ],
      "clinical_settings": [],
      "questions": [],
      "classification": {
        "category": "background",
        "decisionPoints": [],
        "cancerTypeStage": [
          "colorectal_stage_II"
        ],
        "testSpecific": []
      },
      "has_decision_context": true,
      "has_direct_quotes": false,
      "has_guardrail": false
    },
    {
      "id": 171,
      "title": "Clinical validation data for RaDaR assay in non-small cell lung cancer from the LUCID study",
      "source_type": "extracted_publication",
      "source_id": "ext-1770163720892-9d7gtc",
      "evidence_type": "observational",
      "is_superseded": false,
      "cancer_types": [
        "lung_nsclc"
      ],
      "clinical_settings": [],
      "questions": [],
      "classification": {
        "category": "data_point",
        "decisionPoints": [],
        "cancerTypeStage": [
          "lung_nsclc"
        ],
        "testSpecific": [
          "RaDaR"
        ]
      },
      "has_decision_context": true,
      "has_direct_quotes": false,
      "has_guardrail": false
    },
    {
      "id": 172,
      "title": "Circulating microRNAs as prognostic therapy biomarkers in head and neck cancer patients.",
      "source_type": "pubmed",
      "source_id": "26057452",
      "evidence_type": "observational",
      "is_superseded": false,
      "cancer_types": [
        "multi_solid"
      ],
      "clinical_settings": [],
      "questions": [],
      "classification": {
        "category": "background",
        "decisionPoints": [],
        "cancerTypeStage": [
          "multi_solid_stage_III"
        ],
        "testSpecific": [
          "RaDaR"
        ]
      },
      "has_decision_context": true,
      "has_direct_quotes": false,
      "has_guardrail": false
    },
    {
      "id": 174,
      "title": "2021 Update on MRD in acute myeloid leukemia: a consensus document from the European LeukemiaNet MRD Working Party.",
      "source_type": "pubmed",
      "source_id": "34724563",
      "evidence_type": "observational",
      "is_superseded": false,
      "cancer_types": [
        "multi_solid"
      ],
      "clinical_settings": [],
      "questions": [],
      "classification": {
        "category": "decision_support",
        "decisionPoints": [],
        "cancerTypeStage": [
          "multi_solid"
        ],
        "testSpecific": [
          "clonoSEQ"
        ]
      },
      "has_decision_context": true,
      "has_direct_quotes": false,
      "has_guardrail": false
    },
    {
      "id": 175,
      "title": "International Myeloma Working Group updated criteria for the diagnosis of multiple myeloma.",
      "source_type": "pubmed",
      "source_id": "25439696",
      "evidence_type": "consensus",
      "is_superseded": false,
      "cancer_types": [
        "multi_solid"
      ],
      "clinical_settings": [],
      "questions": [],
      "classification": {
        "category": "decision_support",
        "decisionPoints": [],
        "cancerTypeStage": [
          "multi_solid"
        ],
        "testSpecific": []
      },
      "has_decision_context": true,
      "has_direct_quotes": false,
      "has_guardrail": false
    },
    {
      "id": 176,
      "title": "Teclistamab in Relapsed or Refractory Multiple Myeloma.",
      "source_type": "pubmed",
      "source_id": "35661166",
      "evidence_type": "rct_results",
      "is_superseded": false,
      "cancer_types": [
        "multi_solid"
      ],
      "clinical_settings": [],
      "questions": [],
      "classification": {
        "category": "background",
        "decisionPoints": [],
        "cancerTypeStage": [
          "multi_solid"
        ],
        "testSpecific": []
      },
      "has_decision_context": true,
      "has_direct_quotes": false,
      "has_guardrail": false
    },
    {
      "id": 178,
      "title": "Daratumumab plus carfilzomib and dexamethasone in patients with relapsed or refractory multiple myeloma.",
      "source_type": "pubmed",
      "source_id": "31113777",
      "evidence_type": "observational",
      "is_superseded": false,
      "cancer_types": [
        "multi_solid"
      ],
      "clinical_settings": [],
      "questions": [],
      "classification": {
        "category": "background",
        "decisionPoints": [],
        "cancerTypeStage": [
          "multi_solid"
        ],
        "testSpecific": [
          "clonoSEQ"
        ]
      },
      "has_decision_context": true,
      "has_direct_quotes": false,
      "has_guardrail": false
    },
    {
      "id": 179,
      "title": "Noninvasive monitoring of diffuse large B-cell lymphoma by immunoglobulin high-throughput sequencing.",
      "source_type": "pubmed",
      "source_id": "25887775",
      "evidence_type": "observational",
      "is_superseded": false,
      "cancer_types": [
        "multi_solid"
      ],
      "clinical_settings": [],
      "questions": [],
      "classification": {
        "category": "background",
        "decisionPoints": [],
        "cancerTypeStage": [
          "multi_solid"
        ],
        "testSpecific": [
          "clonoSEQ"
        ]
      },
      "has_decision_context": true,
      "has_direct_quotes": false,
      "has_guardrail": false
    },
    {
      "id": 180,
      "title": "A better approach to mismatched HSCT than PTCY?",
      "source_type": "pubmed",
      "source_id": "39088235",
      "evidence_type": "observational",
      "is_superseded": false,
      "cancer_types": [
        "multi_solid"
      ],
      "clinical_settings": [],
      "questions": [],
      "classification": {
        "category": "background",
        "decisionPoints": [],
        "cancerTypeStage": [
          "multi_solid"
        ],
        "testSpecific": [
          "clonoSEQ"
        ]
      },
      "has_decision_context": true,
      "has_direct_quotes": false,
      "has_guardrail": false
    },
    {
      "id": 181,
      "title": "Multiple myeloma: EHA-ESMO Clinical Practice Guidelines for diagnosis, treatment and follow-up&#x2020;.",
      "source_type": "pubmed",
      "source_id": "33549387",
      "evidence_type": "consensus",
      "is_superseded": false,
      "cancer_types": [
        "multi_solid"
      ],
      "clinical_settings": [],
      "questions": [],
      "classification": {
        "category": "decision_support",
        "decisionPoints": [],
        "cancerTypeStage": [
          "multi_solid"
        ],
        "testSpecific": []
      },
      "has_decision_context": true,
      "has_direct_quotes": false,
      "has_guardrail": false
    },
    {
      "id": 182,
      "title": "ESMO Clinical Practice Guideline interim update on the use of targeted therapy in acute lymphoblastic leukaemia.",
      "source_type": "pubmed",
      "source_id": "37832649",
      "evidence_type": "guideline",
      "is_superseded": false,
      "cancer_types": [
        "multi_solid"
      ],
      "clinical_settings": [],
      "questions": [],
      "classification": {
        "category": "decision_support",
        "decisionPoints": [],
        "cancerTypeStage": [
          "multi_solid"
        ],
        "testSpecific": []
      },
      "has_decision_context": true,
      "has_direct_quotes": false,
      "has_guardrail": false
    },
    {
      "id": 183,
      "title": "Seven-year outcomes of venetoclax-ibrutinib therapy in mantle cell lymphoma: durable responses and treatment-free remissions.",
      "source_type": "pubmed",
      "source_id": "38662991",
      "evidence_type": "observational",
      "is_superseded": false,
      "cancer_types": [
        "multi_solid"
      ],
      "clinical_settings": [],
      "questions": [],
      "classification": {
        "category": "background",
        "decisionPoints": [],
        "cancerTypeStage": [
          "multi_solid"
        ],
        "testSpecific": [
          "clonoSEQ"
        ]
      },
      "has_decision_context": true,
      "has_direct_quotes": false,
      "has_guardrail": false
    },
    {
      "id": 184,
      "title": "Health economic impact of liquid biopsies in cancer management.",
      "source_type": "pubmed",
      "source_id": "30052095",
      "evidence_type": "observational",
      "is_superseded": false,
      "cancer_types": [
        "colorectal"
      ],
      "clinical_settings": [],
      "questions": [],
      "classification": {
        "category": "background",
        "decisionPoints": [],
        "cancerTypeStage": [
          "colorectal"
        ],
        "testSpecific": []
      },
      "has_decision_context": true,
      "has_direct_quotes": false,
      "has_guardrail": false
    },
    {
      "id": 185,
      "title": "Bone marrow micrometastases and gastrointestinal cancer detection and significance.",
      "source_type": "pubmed",
      "source_id": "10925963",
      "evidence_type": "observational",
      "is_superseded": false,
      "cancer_types": [
        "colorectal"
      ],
      "clinical_settings": [],
      "questions": [],
      "classification": {
        "category": "background",
        "decisionPoints": [],
        "cancerTypeStage": [
          "colorectal"
        ],
        "testSpecific": []
      },
      "has_decision_context": true,
      "has_direct_quotes": false,
      "has_guardrail": false
    },
    {
      "id": 186,
      "title": "Systematic literature review of health economic models developed for multiple myeloma to support future analyses.",
      "source_type": "pubmed",
      "source_id": "36346000",
      "evidence_type": "observational",
      "is_superseded": false,
      "cancer_types": [
        "colorectal"
      ],
      "clinical_settings": [],
      "questions": [],
      "classification": {
        "category": "background",
        "decisionPoints": [],
        "cancerTypeStage": [
          "colorectal"
        ],
        "testSpecific": []
      },
      "has_decision_context": true,
      "has_direct_quotes": false,
      "has_guardrail": false
    },
    {
      "id": 187,
      "title": "A Cell-free DNA Blood-Based Test for Colorectal Cancer Screening",
      "source_type": "pubmed",
      "source_id": "38477985",
      "evidence_type": "rct_results",
      "is_superseded": false,
      "cancer_types": [
        "colorectal"
      ],
      "clinical_settings": [],
      "questions": [],
      "classification": {
        "category": "background",
        "decisionPoints": [],
        "cancerTypeStage": [
          "colorectal"
        ],
        "testSpecific": []
      },
      "has_decision_context": true,
      "has_direct_quotes": false,
      "has_guardrail": false
    },
    {
      "id": 188,
      "title": "Circulating tumour DNA in patients with hepatocellular carcinoma across tumour stages and treatments.",
      "source_type": "pubmed",
      "source_id": "39054058",
      "evidence_type": "rct_results",
      "is_superseded": false,
      "cancer_types": [
        "colorectal"
      ],
      "clinical_settings": [],
      "questions": [],
      "classification": {
        "category": "background",
        "decisionPoints": [],
        "cancerTypeStage": [
          "colorectal"
        ],
        "testSpecific": []
      },
      "has_decision_context": true,
      "has_direct_quotes": false,
      "has_guardrail": false
    },
    {
      "id": 189,
      "title": "High accuracy of a blood ctDNA-based multimodal test to detect colorectal cancer",
      "source_type": "pubmed",
      "source_id": "37805131",
      "evidence_type": "observational",
      "is_superseded": false,
      "cancer_types": [
        "colorectal"
      ],
      "clinical_settings": [],
      "questions": [],
      "classification": {
        "category": "background",
        "decisionPoints": [],
        "cancerTypeStage": [
          "colorectal"
        ],
        "testSpecific": []
      },
      "has_decision_context": true,
      "has_direct_quotes": false,
      "has_guardrail": false
    },
    {
      "id": 190,
      "title": "Validation of a multi-modal blood-based test for the detection of colorectal cancer with sub single molecule sensitivity",
      "source_type": "extracted_publication",
      "source_id": "ext-1770163878194-24qmha",
      "evidence_type": "observational",
      "is_superseded": false,
      "cancer_types": [
        "colorectal"
      ],
      "clinical_settings": [],
      "questions": [],
      "classification": {
        "category": "background",
        "decisionPoints": [],
        "cancerTypeStage": [
          "colorectal"
        ],
        "testSpecific": []
      },
      "has_decision_context": true,
      "has_direct_quotes": false,
      "has_guardrail": false
    },
    {
      "id": 191,
      "title": "Prospective study of a multi-modal blood-based test for colorectal cancer screening",
      "source_type": "extracted_publication",
      "source_id": "ext-1770163878917-hizl0g",
      "evidence_type": "observational",
      "is_superseded": false,
      "cancer_types": [
        "colorectal"
      ],
      "clinical_settings": [],
      "questions": [],
      "classification": {
        "category": "background",
        "decisionPoints": [],
        "cancerTypeStage": [
          "colorectal"
        ],
        "testSpecific": []
      },
      "has_decision_context": true,
      "has_direct_quotes": false,
      "has_guardrail": false
    },
    {
      "id": 192,
      "title": "Development of a highly sensitive multicancer, targeted, cell-free DNA epigenomic assay for integrated screening of lung and colorectal cancer",
      "source_type": "extracted_publication",
      "source_id": "ext-1770163879618-gy3t7u",
      "evidence_type": "observational",
      "is_superseded": false,
      "cancer_types": [
        "colorectal",
        "lung_nsclc"
      ],
      "clinical_settings": [],
      "questions": [],
      "classification": {
        "category": "background",
        "decisionPoints": [],
        "cancerTypeStage": [
          "colorectal",
          "lung_nsclc"
        ],
        "testSpecific": []
      },
      "has_decision_context": true,
      "has_direct_quotes": false,
      "has_guardrail": false
    },
    {
      "id": 193,
      "title": "Addition of Durvalumab to BCG After TURBT for BCG-Naive, High-Risk NMIBC",
      "source_type": "extracted_publication",
      "source_id": "ext-1770163898420-pmyq58",
      "evidence_type": "rct_results",
      "is_superseded": false,
      "cancer_types": [
        "bladder"
      ],
      "clinical_settings": [],
      "questions": [],
      "classification": {
        "category": "background",
        "decisionPoints": [],
        "cancerTypeStage": [
          "bladder"
        ],
        "testSpecific": []
      },
      "has_decision_context": true,
      "has_direct_quotes": false,
      "has_guardrail": true
    },
    {
      "id": 194,
      "title": "Intensity-Modulated Proton vs Photon Radiotherapy in Oropharyngeal Cancer",
      "source_type": "extracted_publication",
      "source_id": "ext-1770163899182-6shfmw",
      "evidence_type": "rct_results",
      "is_superseded": false,
      "cancer_types": [
        "multi_solid"
      ],
      "clinical_settings": [],
      "questions": [],
      "classification": {
        "category": "background",
        "decisionPoints": [],
        "cancerTypeStage": [
          "multi_solid_stage_III"
        ],
        "testSpecific": []
      },
      "has_decision_context": true,
      "has_direct_quotes": false,
      "has_guardrail": true
    },
    {
      "id": 195,
      "title": "Global Cancer Survival Gaps Assessed Using a Country-Level Machine-Learning Framework",
      "source_type": "extracted_publication",
      "source_id": "ext-1770163900089-99b5d4",
      "evidence_type": "observational",
      "is_superseded": false,
      "cancer_types": [
        "multi_solid"
      ],
      "clinical_settings": [],
      "questions": [],
      "classification": {
        "category": "background",
        "decisionPoints": [],
        "cancerTypeStage": [
          "multi_solid"
        ],
        "testSpecific": []
      },
      "has_decision_context": true,
      "has_direct_quotes": false,
      "has_guardrail": true
    },
    {
      "id": 196,
      "title": "NCT04264702: BESPOKE Study of ctDNA Guided Therapy in Colorectal Cancer",
      "source_type": "clinicaltrials",
      "source_id": "trial-NCT04264702",
      "evidence_type": "rct_results",
      "is_superseded": false,
      "cancer_types": [],
      "clinical_settings": [],
      "questions": [],
      "classification": {
        "category": "background",
        "decisionPoints": [],
        "cancerTypeStage": [],
        "testSpecific": []
      },
      "has_decision_context": false,
      "has_direct_quotes": false,
      "has_guardrail": false
    },
    {
      "id": 197,
      "title": "CIRCULATE: CIRCULATING TUMOR DNA BASED DECISION FOR ADJUVANT TREATMENT IN COLON CANCER STAGE II",
      "source_type": "clinicaltrials",
      "source_id": "trial-NCT04120701",
      "evidence_type": "rct_results",
      "is_superseded": false,
      "cancer_types": [],
      "clinical_settings": [],
      "questions": [],
      "classification": {
        "category": "background",
        "decisionPoints": [],
        "cancerTypeStage": [],
        "testSpecific": []
      },
      "has_decision_context": false,
      "has_direct_quotes": false,
      "has_guardrail": false
    },
    {
      "id": 198,
      "title": "NCT04302025: A Study of Multiple Therapies in Biomarker-selected Participants With Resectable Stages IB-III Non-small Cell Lung Cancer (NSCLC)",
      "source_type": "clinicaltrials",
      "source_id": "trial-NCT04302025",
      "evidence_type": "rct_results",
      "is_superseded": false,
      "cancer_types": [],
      "clinical_settings": [],
      "questions": [],
      "classification": {
        "category": "background",
        "decisionPoints": [],
        "cancerTypeStage": [],
        "testSpecific": []
      },
      "has_decision_context": false,
      "has_direct_quotes": false,
      "has_guardrail": false
    },
    {
      "id": 199,
      "title": "GLORIA: Glucose Homeostasis, Metabolomics and Pregnancy Outcomes After Bariatric Surgery",
      "source_type": "clinicaltrials",
      "source_id": "trial-NCT05084339",
      "evidence_type": "rct_results",
      "is_superseded": false,
      "cancer_types": [],
      "clinical_settings": [],
      "questions": [],
      "classification": {
        "category": "background",
        "decisionPoints": [],
        "cancerTypeStage": [],
        "testSpecific": []
      },
      "has_decision_context": false,
      "has_direct_quotes": false,
      "has_guardrail": false
    },
    {
      "id": 200,
      "title": "MERMAID-1: Phase III Study to Determine the Efficacy of Durvalumab in Combination With Chemotherapy in Completely Resected Stage II-III Non-small Cell Lung Cancer (NSCLC)",
      "source_type": "clinicaltrials",
      "source_id": "trial-NCT04385368",
      "evidence_type": "rct_results",
      "is_superseded": false,
      "cancer_types": [],
      "clinical_settings": [],
      "questions": [],
      "classification": {
        "category": "background",
        "decisionPoints": [],
        "cancerTypeStage": [],
        "testSpecific": []
      },
      "has_decision_context": false,
      "has_direct_quotes": false,
      "has_guardrail": false
    },
    {
      "id": 201,
      "title": "CIRCULATE: Circulating Tumour DNA Based Decision for Adjuvant Treatment in Colon Cancer Stage II Evaluation",
      "source_type": "clinicaltrials",
      "source_id": "trial-NCT04089631",
      "evidence_type": "rct_results",
      "is_superseded": false,
      "cancer_types": [],
      "clinical_settings": [],
      "questions": [],
      "classification": {
        "category": "background",
        "decisionPoints": [],
        "cancerTypeStage": [],
        "testSpecific": []
      },
      "has_decision_context": false,
      "has_direct_quotes": false,
      "has_guardrail": false
    },
    {
      "id": 202,
      "title": "NCT05102045: The Effects of Repetitive Transcranial Magnetic Stimulation in Patients With Alzheimer's Disease",
      "source_type": "clinicaltrials",
      "source_id": "trial-NCT05102045",
      "evidence_type": "rct_results",
      "is_superseded": false,
      "cancer_types": [],
      "clinical_settings": [],
      "questions": [],
      "classification": {
        "category": "background",
        "decisionPoints": [],
        "cancerTypeStage": [],
        "testSpecific": []
      },
      "has_decision_context": false,
      "has_direct_quotes": false,
      "has_guardrail": false
    },
    {
      "id": 203,
      "title": "NCT05078866: Cancer Preventive Vaccine Nous-209 for Lynch Syndrome Patients",
      "source_type": "clinicaltrials",
      "source_id": "trial-NCT05078866",
      "evidence_type": "rct_results",
      "is_superseded": false,
      "cancer_types": [],
      "clinical_settings": [],
      "questions": [],
      "classification": {
        "category": "background",
        "decisionPoints": [],
        "cancerTypeStage": [],
        "testSpecific": []
      },
      "has_decision_context": false,
      "has_direct_quotes": false,
      "has_guardrail": false
    },
    {
      "id": 204,
      "title": "POTENTIATE: Study of the CHK1 Inhibitor BBI-355, an ecDNA-directed Therapy (ecDTx), and the RNR Inhibitor BBI-825, in Subjects With Tumors With Oncogene Amplifications",
      "source_type": "clinicaltrials",
      "source_id": "trial-NCT05827614",
      "evidence_type": "rct_results",
      "is_superseded": false,
      "cancer_types": [],
      "clinical_settings": [],
      "questions": [],
      "classification": {
        "category": "background",
        "decisionPoints": [],
        "cancerTypeStage": [],
        "testSpecific": []
      },
      "has_decision_context": false,
      "has_direct_quotes": false,
      "has_guardrail": false
    },
    {
      "id": 205,
      "title": "NCT03832569: Study of Pembrolizumab Following Surgery in Patients With Microsatellite Instability High (MSI-H) Solid Tumors",
      "source_type": "clinicaltrials",
      "source_id": "trial-NCT03832569",
      "evidence_type": "rct_results",
      "is_superseded": false,
      "cancer_types": [],
      "clinical_settings": [],
      "questions": [],
      "classification": {
        "category": "background",
        "decisionPoints": [],
        "cancerTypeStage": [],
        "testSpecific": []
      },
      "has_decision_context": false,
      "has_direct_quotes": false,
      "has_guardrail": false
    },
    {
      "id": 206,
      "title": "NCT04585477: Adjuvant ctDNA-Adapted Personalized Treatment in Early Stage NSCLC (ADAPT-E)",
      "source_type": "clinicaltrials",
      "source_id": "trial-NCT04585477",
      "evidence_type": "rct_results",
      "is_superseded": false,
      "cancer_types": [],
      "clinical_settings": [],
      "questions": [],
      "classification": {
        "category": "background",
        "decisionPoints": [],
        "cancerTypeStage": [],
        "testSpecific": []
      },
      "has_decision_context": false,
      "has_direct_quotes": false,
      "has_guardrail": false
    },
    {
      "id": 207,
      "title": "FMD: Immersive Virtual Reality in Functional Motor Disorders",
      "source_type": "clinicaltrials",
      "source_id": "trial-NCT05581134",
      "evidence_type": "rct_results",
      "is_superseded": false,
      "cancer_types": [],
      "clinical_settings": [],
      "questions": [],
      "classification": {
        "category": "background",
        "decisionPoints": [],
        "cancerTypeStage": [],
        "testSpecific": []
      },
      "has_decision_context": false,
      "has_direct_quotes": false,
      "has_guardrail": false
    },
    {
      "id": 208,
      "title": "IMPROVE-IT: IMPROVE Intervention Trial Implementing Non-invasive Circulating Tumor DNA Analysis to Optimize the Operative and Postoperative Treatment for Patients With Colorectal Cancer",
      "source_type": "clinicaltrials",
      "source_id": "trial-NCT03748680",
      "evidence_type": "rct_results",
      "is_superseded": false,
      "cancer_types": [],
      "clinical_settings": [],
      "questions": [],
      "classification": {
        "category": "background",
        "decisionPoints": [],
        "cancerTypeStage": [],
        "testSpecific": []
      },
      "has_decision_context": false,
      "has_direct_quotes": false,
      "has_guardrail": false
    },
    {
      "id": 209,
      "title": "Cost-effectiveness of blood-based colorectal cancer screening – a simulation model incorporating real-world longitudinal adherence",
      "source_type": "pubmed",
      "source_id": "39894975",
      "evidence_type": "observational",
      "is_superseded": false,
      "cancer_types": [
        "colorectal"
      ],
      "clinical_settings": [],
      "questions": [],
      "classification": {
        "category": "background",
        "decisionPoints": [],
        "cancerTypeStage": [
          "colorectal"
        ],
        "testSpecific": []
      },
      "has_decision_context": true,
      "has_direct_quotes": false,
      "has_guardrail": false
    },
    {
      "id": 210,
      "title": "Real-World Adherence to Repeat Testing for Stool-Based Non-Invasive Colorectal Cancer Screening Tests Among Individuals With Average Risk",
      "source_type": "extracted_publication",
      "source_id": "ext-1770188064487-ipq0w3",
      "evidence_type": "observational",
      "is_superseded": false,
      "cancer_types": [
        "colorectal"
      ],
      "clinical_settings": [],
      "questions": [],
      "classification": {
        "category": "background",
        "decisionPoints": [],
        "cancerTypeStage": [
          "colorectal"
        ],
        "testSpecific": []
      },
      "has_decision_context": true,
      "has_direct_quotes": false,
      "has_guardrail": false
    },
    {
      "id": 211,
      "title": "Population health outcomes of blood-based screening for colorectal cancer in comparison to current screening modalities: insights from a discrete-event simulation model incorporating longitudinal adherence",
      "source_type": "pubmed",
      "source_id": "39037853",
      "evidence_type": "observational",
      "is_superseded": false,
      "cancer_types": [
        "colorectal"
      ],
      "clinical_settings": [],
      "questions": [],
      "classification": {
        "category": "background",
        "decisionPoints": [],
        "cancerTypeStage": [
          "colorectal"
        ],
        "testSpecific": []
      },
      "has_decision_context": true,
      "has_direct_quotes": false,
      "has_guardrail": false
    },
    {
      "id": 212,
      "title": "A Cell-free DNA Blood-Based Test for Colorectal Cancer Screening",
      "source_type": "extracted_publication",
      "source_id": "ext-1770188065893-p57yjx",
      "evidence_type": "rct_results",
      "is_superseded": false,
      "cancer_types": [
        "colorectal"
      ],
      "clinical_settings": [],
      "questions": [],
      "classification": {
        "category": "background",
        "decisionPoints": [],
        "cancerTypeStage": [
          "colorectal"
        ],
        "testSpecific": []
      },
      "has_decision_context": true,
      "has_direct_quotes": false,
      "has_guardrail": false
    },
    {
      "id": 213,
      "title": "Blood-based colorectal cancer screening in an integrated health system: a randomised trial of patient adherence",
      "source_type": "extracted_publication",
      "source_id": "ext-1770188066565-l6d3q3",
      "evidence_type": "rct_results",
      "is_superseded": false,
      "cancer_types": [
        "colorectal"
      ],
      "clinical_settings": [],
      "questions": [],
      "classification": {
        "category": "background",
        "decisionPoints": [],
        "cancerTypeStage": [
          "colorectal"
        ],
        "testSpecific": []
      },
      "has_decision_context": true,
      "has_direct_quotes": false,
      "has_guardrail": false
    },
    {
      "id": 214,
      "title": "\"I was screaming hallelujah\": Patient and provider perceptions of blood-based testing for colorectal cancer screening",
      "source_type": "pubmed",
      "source_id": "38127900",
      "evidence_type": "observational",
      "is_superseded": false,
      "cancer_types": [
        "colorectal"
      ],
      "clinical_settings": [],
      "questions": [],
      "classification": {
        "category": "background",
        "decisionPoints": [],
        "cancerTypeStage": [
          "colorectal"
        ],
        "testSpecific": []
      },
      "has_decision_context": true,
      "has_direct_quotes": false,
      "has_guardrail": false
    },
    {
      "id": 215,
      "title": "High accuracy of a blood ctDNA-based multimodal test to detect colorectal cancer",
      "source_type": "extracted_publication",
      "source_id": "ext-1770188067989-oqw3ec",
      "evidence_type": "observational",
      "is_superseded": false,
      "cancer_types": [
        "colorectal"
      ],
      "clinical_settings": [],
      "questions": [],
      "classification": {
        "category": "background",
        "decisionPoints": [],
        "cancerTypeStage": [
          "colorectal"
        ],
        "testSpecific": []
      },
      "has_decision_context": true,
      "has_direct_quotes": false,
      "has_guardrail": false
    },
    {
      "id": 216,
      "title": "Validation of a multi-modal blood-based test for the detection of colorectal cancer with sub single molecule sensitivity",
      "source_type": "extracted_publication",
      "source_id": "ext-1770188068655-nyj3z6",
      "evidence_type": "observational",
      "is_superseded": false,
      "cancer_types": [
        "colorectal"
      ],
      "clinical_settings": [],
      "questions": [],
      "classification": {
        "category": "background",
        "decisionPoints": [],
        "cancerTypeStage": [
          "colorectal"
        ],
        "testSpecific": []
      },
      "has_decision_context": true,
      "has_direct_quotes": false,
      "has_guardrail": false
    },
    {
      "id": 217,
      "title": "Prospective study of a multi-modal blood-based test for colorectal cancer screening",
      "source_type": "extracted_publication",
      "source_id": "ext-1770188069386-32nqyt",
      "evidence_type": "observational",
      "is_superseded": false,
      "cancer_types": [
        "colorectal"
      ],
      "clinical_settings": [],
      "questions": [],
      "classification": {
        "category": "background",
        "decisionPoints": [],
        "cancerTypeStage": [
          "colorectal"
        ],
        "testSpecific": []
      },
      "has_decision_context": true,
      "has_direct_quotes": false,
      "has_guardrail": false
    },
    {
      "id": 218,
      "title": "Development of a highly sensitive multicancer, targeted, cell-free DNA epigenomic assay for integrated screening of lung and colorectal cancer",
      "source_type": "extracted_publication",
      "source_id": "ext-1770188070069-syl22c",
      "evidence_type": "observational",
      "is_superseded": false,
      "cancer_types": [
        "colorectal",
        "multi_solid"
      ],
      "clinical_settings": [],
      "questions": [],
      "classification": {
        "category": "background",
        "decisionPoints": [],
        "cancerTypeStage": [
          "colorectal",
          "multi_solid"
        ],
        "testSpecific": []
      },
      "has_decision_context": true,
      "has_direct_quotes": false,
      "has_guardrail": false
    },
    {
      "id": 219,
      "title": "Multimodal circulating tumor DNA blood-based colorectal cancer screening test demonstrates clinically meaningful sensitivity across multiple clinical parameters",
      "source_type": "extracted_publication",
      "source_id": "ext-1770188070791-i3odue",
      "evidence_type": "observational",
      "is_superseded": false,
      "cancer_types": [
        "colorectal"
      ],
      "clinical_settings": [],
      "questions": [],
      "classification": {
        "category": "background",
        "decisionPoints": [],
        "cancerTypeStage": [
          "colorectal"
        ],
        "testSpecific": []
      },
      "has_decision_context": true,
      "has_direct_quotes": false,
      "has_guardrail": false
    },
    {
      "id": 220,
      "title": "Multimodal circulating tumor DNA (ctDNA) colorectal neoplasia detection assay for asymptomatic and early-stage colorectal cancer",
      "source_type": "extracted_publication",
      "source_id": "ext-1770188071544-13mjzc",
      "evidence_type": "observational",
      "is_superseded": false,
      "cancer_types": [
        "colorectal"
      ],
      "clinical_settings": [],
      "questions": [],
      "classification": {
        "category": "data_point",
        "decisionPoints": [],
        "cancerTypeStage": [
          "colorectal"
        ],
        "testSpecific": []
      },
      "has_decision_context": true,
      "has_direct_quotes": false,
      "has_guardrail": false
    },
    {
      "id": 221,
      "title": "Addition of Durvalumab to BCG After TURBT for BCG-Naive, High-Risk NMIBC (POTOMAC trial)",
      "source_type": "extracted_publication",
      "source_id": "ext-1770189601671-0qobhq",
      "evidence_type": "rct_results",
      "is_superseded": false,
      "cancer_types": [
        "multi_solid"
      ],
      "clinical_settings": [],
      "questions": [],
      "classification": {
        "category": "background",
        "decisionPoints": [],
        "cancerTypeStage": [
          "multi_solid"
        ],
        "testSpecific": []
      },
      "has_decision_context": true,
      "has_direct_quotes": false,
      "has_guardrail": true
    },
    {
      "id": 222,
      "title": "Intensity-Modulated Proton vs Photon Radiotherapy in Oropharyngeal Cancer",
      "source_type": "extracted_publication",
      "source_id": "ext-1770189602689-kn2003",
      "evidence_type": "rct_results",
      "is_superseded": false,
      "cancer_types": [
        "multi_solid"
      ],
      "clinical_settings": [],
      "questions": [],
      "classification": {
        "category": "background",
        "decisionPoints": [],
        "cancerTypeStage": [
          "multi_solid_stage_III"
        ],
        "testSpecific": []
      },
      "has_decision_context": true,
      "has_direct_quotes": false,
      "has_guardrail": true
    },
    {
      "id": 223,
      "title": "Global Cancer Survival Gaps Assessed Using a Country-Level Machine-Learning Framework",
      "source_type": "extracted_publication",
      "source_id": "ext-1770189603433-tddm1z",
      "evidence_type": "observational",
      "is_superseded": false,
      "cancer_types": [
        "multi_solid"
      ],
      "clinical_settings": [],
      "questions": [],
      "classification": {
        "category": "background",
        "decisionPoints": [],
        "cancerTypeStage": [
          "multi_solid"
        ],
        "testSpecific": []
      },
      "has_decision_context": true,
      "has_direct_quotes": false,
      "has_guardrail": true
    },
    {
      "id": 224,
      "title": "Not fully specified - Multiple Myeloma study",
      "source_type": "extracted_publication",
      "source_id": "ext-1770189674875-p6dg1g",
      "evidence_type": "observational",
      "is_superseded": false,
      "cancer_types": [
        "multi_solid"
      ],
      "clinical_settings": [],
      "questions": [],
      "classification": {
        "category": "background",
        "decisionPoints": [],
        "cancerTypeStage": [
          "multi_solid"
        ],
        "testSpecific": []
      },
      "has_decision_context": true,
      "has_direct_quotes": false,
      "has_guardrail": false
    },
    {
      "id": 225,
      "title": "Not fully specified - ALL study comparing clonoSEQ to flow cytometry",
      "source_type": "extracted_publication",
      "source_id": "ext-1770189675802-lblnnd",
      "evidence_type": "observational",
      "is_superseded": false,
      "cancer_types": [
        "multi_solid"
      ],
      "clinical_settings": [],
      "questions": [],
      "classification": {
        "category": "background",
        "decisionPoints": [],
        "cancerTypeStage": [
          "multi_solid"
        ],
        "testSpecific": [
          "clonoSEQ"
        ]
      },
      "has_decision_context": true,
      "has_direct_quotes": false,
      "has_guardrail": false
    },
    {
      "id": 226,
      "title": "International Myeloma Working Group consensus criteria",
      "source_type": "pubmed",
      "source_id": "27511158",
      "evidence_type": "consensus",
      "is_superseded": false,
      "cancer_types": [
        "multi_solid"
      ],
      "clinical_settings": [],
      "questions": [],
      "classification": {
        "category": "decision_support",
        "decisionPoints": [],
        "cancerTypeStage": [
          "multi_solid"
        ],
        "testSpecific": []
      },
      "has_decision_context": true,
      "has_direct_quotes": false,
      "has_guardrail": false
    },
    {
      "id": 227,
      "title": "Not fully specified - CASTOR study",
      "source_type": "extracted_publication",
      "source_id": "ext-1770189677309-gw5tkj",
      "evidence_type": "rct_results",
      "is_superseded": false,
      "cancer_types": [
        "multi_solid"
      ],
      "clinical_settings": [],
      "questions": [],
      "classification": {
        "category": "background",
        "decisionPoints": [],
        "cancerTypeStage": [
          "multi_solid"
        ],
        "testSpecific": []
      },
      "has_decision_context": true,
      "has_direct_quotes": false,
      "has_guardrail": false
    },
    {
      "id": 228,
      "title": "Not fully specified - POLLUX study",
      "source_type": "extracted_publication",
      "source_id": "ext-1770189678034-z0jm9a",
      "evidence_type": "rct_results",
      "is_superseded": false,
      "cancer_types": [
        "multi_solid"
      ],
      "clinical_settings": [],
      "questions": [],
      "classification": {
        "category": "background",
        "decisionPoints": [],
        "cancerTypeStage": [
          "multi_solid"
        ],
        "testSpecific": []
      },
      "has_decision_context": true,
      "has_direct_quotes": false,
      "has_guardrail": false
    },
    {
      "id": 229,
      "title": "Not fully specified - MRD assessment predicts outcomes in MM",
      "source_type": "pubmed",
      "source_id": "39467592",
      "evidence_type": "observational",
      "is_superseded": false,
      "cancer_types": [
        "multi_solid"
      ],
      "clinical_settings": [],
      "questions": [],
      "classification": {
        "category": "background",
        "decisionPoints": [],
        "cancerTypeStage": [
          "multi_solid"
        ],
        "testSpecific": []
      },
      "has_decision_context": true,
      "has_direct_quotes": false,
      "has_guardrail": false
    },
    {
      "id": 230,
      "title": "ESMO consensus guidelines for management of patients with metastatic breast cancer",
      "source_type": "extracted_publication",
      "source_id": "ext-1770189679359-vb7my3",
      "evidence_type": "guideline",
      "is_superseded": false,
      "cancer_types": [
        "multi_solid"
      ],
      "clinical_settings": [],
      "questions": [],
      "classification": {
        "category": "decision_support",
        "decisionPoints": [],
        "cancerTypeStage": [
          "multi_solid"
        ],
        "testSpecific": []
      },
      "has_decision_context": true,
      "has_direct_quotes": false,
      "has_guardrail": false
    },
    {
      "id": 231,
      "title": "Not fully specified - NGS-based MRD detection method",
      "source_type": "extracted_publication",
      "source_id": "ext-1770189680013-up6hd9",
      "evidence_type": "observational",
      "is_superseded": false,
      "cancer_types": [
        "multi_solid"
      ],
      "clinical_settings": [],
      "questions": [],
      "classification": {
        "category": "background",
        "decisionPoints": [],
        "cancerTypeStage": [
          "multi_solid"
        ],
        "testSpecific": []
      },
      "has_decision_context": true,
      "has_direct_quotes": false,
      "has_guardrail": false
    },
    {
      "id": 232,
      "title": "Not fully specified - Post-transplant MRD assessment in ALL",
      "source_type": "extracted_publication",
      "source_id": "ext-1770189680655-mymyun",
      "evidence_type": "observational",
      "is_superseded": false,
      "cancer_types": [
        "multi_solid"
      ],
      "clinical_settings": [],
      "questions": [],
      "classification": {
        "category": "background",
        "decisionPoints": [],
        "cancerTypeStage": [
          "multi_solid"
        ],
        "testSpecific": []
      },
      "has_decision_context": true,
      "has_direct_quotes": false,
      "has_guardrail": false
    },
    {
      "id": 233,
      "title": "Not fully specified - European LeukemiaNet recommendations for ALL",
      "source_type": "extracted_publication",
      "source_id": "ext-1770189681312-3swoec",
      "evidence_type": "guideline",
      "is_superseded": false,
      "cancer_types": [
        "multi_solid"
      ],
      "clinical_settings": [],
      "questions": [],
      "classification": {
        "category": "decision_support",
        "decisionPoints": [],
        "cancerTypeStage": [
          "multi_solid"
        ],
        "testSpecific": []
      },
      "has_decision_context": true,
      "has_direct_quotes": false,
      "has_guardrail": false
    },
    {
      "id": 234,
      "title": "Not fully specified - CLL MRD assessment study",
      "source_type": "pubmed",
      "source_id": "30133037",
      "evidence_type": "observational",
      "is_superseded": false,
      "cancer_types": [
        "multi_solid"
      ],
      "clinical_settings": [],
      "questions": [],
      "classification": {
        "category": "background",
        "decisionPoints": [],
        "cancerTypeStage": [
          "multi_solid"
        ],
        "testSpecific": []
      },
      "has_decision_context": true,
      "has_direct_quotes": false,
      "has_guardrail": false
    },
    {
      "id": 235,
      "title": "Adjuvant nivolumab versus placebo for high-risk muscle-invasive urothelial carcinoma: 5-year efficacy and ctDNA results from CheckMate 274",
      "source_type": "pubmed",
      "source_id": "41110694",
      "evidence_type": "rct_results",
      "is_superseded": false,
      "cancer_types": [
        "multi_solid"
      ],
      "clinical_settings": [],
      "questions": [],
      "classification": {
        "category": "background",
        "decisionPoints": [],
        "cancerTypeStage": [
          "multi_solid"
        ],
        "testSpecific": []
      },
      "has_decision_context": true,
      "has_direct_quotes": false,
      "has_guardrail": false
    },
    {
      "id": 236,
      "title": "ctDNA-Guided Adjuvant Atezolizumab in Muscle-Invasive Bladder Cancer",
      "source_type": "pubmed",
      "source_id": "41124204",
      "evidence_type": "rct_results",
      "is_superseded": false,
      "cancer_types": [
        "multi_solid"
      ],
      "clinical_settings": [],
      "questions": [],
      "classification": {
        "category": "background",
        "decisionPoints": [],
        "cancerTypeStage": [
          "multi_solid"
        ],
        "testSpecific": []
      },
      "has_decision_context": true,
      "has_direct_quotes": false,
      "has_guardrail": false
    },
    {
      "id": 237,
      "title": "Tumor Characteristics Associated With Preoperatively Detectable Tumor-Informed Circulating Tumor DNA in Patients With Renal Masses Suspicious for Renal Cell Carcinoma",
      "source_type": "extracted_publication",
      "source_id": "10.1200/PO.24.00281",
      "evidence_type": "prospective_cohort",
      "is_superseded": false,
      "cancer_types": [
        "multi_solid",
        "renal"
      ],
      "clinical_settings": [
        "surveillance",
        "adjuvant",
        "neoadjuvant",
        "metastatic",
        "recurrence_detection"
      ],
      "questions": [],
      "classification": {
        "category": "background",
        "decisionPoints": [],
        "cancerTypeStage": [
          "multi_solid",
          "renal"
        ],
        "testSpecific": []
      },
      "has_decision_context": true,
      "has_direct_quotes": false,
      "has_guardrail": false
    },
    {
      "id": 238,
      "title": "The prognostic significance of circulating tumor DNA in patients with positive lymph node disease after robotic-assisted radical cystectomy: A contemporary analysis",
      "source_type": "pubmed",
      "source_id": "39277526",
      "evidence_type": "prospective_cohort",
      "is_superseded": false,
      "cancer_types": [
        "bladder",
        "multi_solid"
      ],
      "clinical_settings": [
        "neoadjuvant",
        "recurrence_detection",
        "surveillance"
      ],
      "questions": [],
      "classification": {
        "category": "background",
        "decisionPoints": [],
        "cancerTypeStage": [
          "bladder",
          "multi_solid"
        ],
        "testSpecific": []
      },
      "has_decision_context": true,
      "has_direct_quotes": false,
      "has_guardrail": false
    },
    {
      "id": 239,
      "title": "Association of circulating tumor DNA with patient prognosis in surgically resected renal cell carcinoma",
      "source_type": "pubmed",
      "source_id": "40885527",
      "evidence_type": "observational",
      "is_superseded": false,
      "cancer_types": [
        "multi_solid",
        "renal"
      ],
      "clinical_settings": [
        "recurrence_detection",
        "surveillance"
      ],
      "questions": [],
      "classification": {
        "category": "background",
        "decisionPoints": [],
        "cancerTypeStage": [
          "multi_solid",
          "renal"
        ],
        "testSpecific": [
          "Signatera",
          "Natera"
        ]
      },
      "has_decision_context": true,
      "has_direct_quotes": false,
      "has_guardrail": false
    },
    {
      "id": 240,
      "title": "Monitoring response to neoadjuvant chemotherapy in triple negative breast cancer using circulating tumor DNA",
      "source_type": "pubmed",
      "source_id": "37146605",
      "evidence_type": "observational",
      "is_superseded": false,
      "cancer_types": [
        "multi_solid"
      ],
      "clinical_settings": [],
      "questions": [],
      "classification": {
        "category": "background",
        "decisionPoints": [],
        "cancerTypeStage": [
          "multi_solid"
        ],
        "testSpecific": []
      },
      "has_decision_context": true,
      "has_direct_quotes": false,
      "has_guardrail": false
    },
    {
      "id": 241,
      "title": "Neoadjuvant nivolumab or nivolumab plus ipilimumab in early-stage triple-negative breast cancer: a phase 2 adaptive trial",
      "source_type": "extracted_publication",
      "source_id": "10.1038/s41591-024-03249-3",
      "evidence_type": "RCT",
      "is_superseded": false,
      "cancer_types": [
        "breast",
        "multi_solid"
      ],
      "clinical_settings": [
        "neoadjuvant"
      ],
      "questions": [],
      "classification": {
        "category": "background",
        "decisionPoints": [],
        "cancerTypeStage": [
          "breast",
          "multi_solid"
        ],
        "testSpecific": []
      },
      "has_decision_context": true,
      "has_direct_quotes": false,
      "has_guardrail": false
    },
    {
      "id": 242,
      "title": "Predictive Role of Circulating Tumor DNA in Stage III Colon Cancer Treated with Celecoxib: Findings from CALGB (Alliance)/SWOG 80702",
      "source_type": "extracted_publication",
      "source_id": "ext-1770190846126-2t3qmz",
      "evidence_type": "rct_results",
      "is_superseded": false,
      "cancer_types": [
        "multi_solid"
      ],
      "clinical_settings": [],
      "questions": [],
      "classification": {
        "category": "background",
        "decisionPoints": [],
        "cancerTypeStage": [
          "multi_solid_stage_III"
        ],
        "testSpecific": []
      },
      "has_decision_context": true,
      "has_direct_quotes": false,
      "has_guardrail": false
    },
    {
      "id": 243,
      "title": "ctDNA-based molecular residual disease and survival in resectable colorectal cancer",
      "source_type": "pubmed",
      "source_id": "39284954",
      "evidence_type": "observational",
      "is_superseded": false,
      "cancer_types": [
        "colorectal",
        "multi_solid"
      ],
      "clinical_settings": [
        "adjuvant",
        "metastatic",
        "recurrence_detection",
        "surveillance"
      ],
      "questions": [],
      "classification": {
        "category": "background",
        "decisionPoints": [],
        "cancerTypeStage": [
          "colorectal",
          "multi_solid"
        ],
        "testSpecific": []
      },
      "has_decision_context": true,
      "has_direct_quotes": false,
      "has_guardrail": false
    },
    {
      "id": 244,
      "title": "Molecular residual disease and efficacy of adjuvant chemotherapy in patients with colorectal cancer",
      "source_type": "pubmed",
      "source_id": "36646802",
      "evidence_type": "observational",
      "is_superseded": false,
      "cancer_types": [
        "multi_solid"
      ],
      "clinical_settings": [],
      "questions": [],
      "classification": {
        "category": "background",
        "decisionPoints": [],
        "cancerTypeStage": [
          "multi_solid"
        ],
        "testSpecific": []
      },
      "has_decision_context": true,
      "has_direct_quotes": false,
      "has_guardrail": false
    },
    {
      "id": 245,
      "title": "Personalized ctDNA for Monitoring Disease Status in Head and Neck Squamous Cell Carcinoma",
      "source_type": "extracted_publication",
      "source_id": "10.1158/1078-0432.CCR-24-0590",
      "evidence_type": "retrospective_cohort",
      "is_superseded": false,
      "cancer_types": [
        "head_neck",
        "multi_solid"
      ],
      "clinical_settings": [
        "metastatic",
        "recurrence_detection",
        "surveillance"
      ],
      "questions": [],
      "classification": {
        "category": "background",
        "decisionPoints": [],
        "cancerTypeStage": [
          "head_neck",
          "multi_solid"
        ],
        "testSpecific": [
          "Signatera",
          "Natera"
        ]
      },
      "has_decision_context": true,
      "has_direct_quotes": false,
      "has_guardrail": false
    },
    {
      "id": 246,
      "title": "Clinical significance of perioperative minimal residual disease detected by circulating tumor DNA in lung cancer patients with a long follow-up data: An exploratory study",
      "source_type": "extracted_publication",
      "source_id": "10.1016/j.jtocrr.2024.100762",
      "evidence_type": "retrospective_cohort",
      "is_superseded": false,
      "cancer_types": [
        "lung_nsclc",
        "multi_solid"
      ],
      "clinical_settings": [
        "recurrence_detection",
        "surveillance",
        "neoadjuvant",
        "adjuvant"
      ],
      "questions": [],
      "classification": {
        "category": "background",
        "decisionPoints": [],
        "cancerTypeStage": [
          "lung_nsclc",
          "multi_solid"
        ],
        "testSpecific": []
      },
      "has_decision_context": true,
      "has_direct_quotes": false,
      "has_guardrail": false
    },
    {
      "id": 247,
      "title": "Circulating Tumor DNA Assay Detects Merkel Cell Carcinoma Recurrence, Disease Progression, and Minimal Residual Disease: Surveillance and Prognostic Implications",
      "source_type": "pubmed",
      "source_id": "39052958",
      "evidence_type": "observational",
      "is_superseded": false,
      "cancer_types": [
        "merkel_cell",
        "multi_solid"
      ],
      "clinical_settings": [
        "recurrence_detection",
        "surveillance",
        "adjuvant"
      ],
      "questions": [],
      "classification": {
        "category": "background",
        "decisionPoints": [],
        "cancerTypeStage": [
          "merkel_cell",
          "multi_solid"
        ],
        "testSpecific": []
      },
      "has_decision_context": true,
      "has_direct_quotes": false,
      "has_guardrail": false
    },
    {
      "id": 248,
      "title": "Personalized circulating tumor DNA analysis as a predictive biomarker in solid tumor patients treated with pembrolizumab",
      "source_type": "pubmed",
      "source_id": "35121950",
      "evidence_type": "observational",
      "is_superseded": false,
      "cancer_types": [
        "multi_solid"
      ],
      "clinical_settings": [],
      "questions": [],
      "classification": {
        "category": "background",
        "decisionPoints": [],
        "cancerTypeStage": [
          "multi_solid"
        ],
        "testSpecific": []
      },
      "has_decision_context": true,
      "has_direct_quotes": false,
      "has_guardrail": false
    },
    {
      "id": 249,
      "title": "Circulating tumor DNA analysis detects minimal residual disease and predicts recurrence in patients with stage II colon cancer",
      "source_type": "pubmed",
      "source_id": "39316995",
      "evidence_type": "prospective_cohort",
      "is_superseded": false,
      "cancer_types": [
        "colorectal",
        "multi_solid"
      ],
      "clinical_settings": [
        "recurrence_detection",
        "surveillance",
        "adjuvant"
      ],
      "questions": [],
      "classification": {
        "category": "background",
        "decisionPoints": [],
        "cancerTypeStage": [
          "colorectal_stage_II",
          "multi_solid_stage_II"
        ],
        "testSpecific": []
      },
      "has_decision_context": true,
      "has_direct_quotes": false,
      "has_guardrail": true
    },
    {
      "id": 250,
      "title": "Adjuvant fluorouracil, leucovorin, and oxaliplatin in stage II to III colon cancer: updated 10-year survival and outcomes according to BRAF mutation and mismatch repair status of the MOSAIC study",
      "source_type": "extracted_publication",
      "source_id": "ext-1770190933845-gxjtzw",
      "evidence_type": "rct_results",
      "is_superseded": false,
      "cancer_types": [
        "multi_solid"
      ],
      "clinical_settings": [],
      "questions": [],
      "classification": {
        "category": "background",
        "decisionPoints": [],
        "cancerTypeStage": [
          "multi_solid_stage_II"
        ],
        "testSpecific": []
      },
      "has_decision_context": true,
      "has_direct_quotes": false,
      "has_guardrail": true
    },
    {
      "id": 251,
      "title": "Adjuvant therapy for completely resected stage II colon cancer",
      "source_type": "pubmed",
      "source_id": "24379564",
      "evidence_type": "meta_analysis",
      "is_superseded": false,
      "cancer_types": [
        "multi_solid"
      ],
      "clinical_settings": [],
      "questions": [],
      "classification": {
        "category": "background",
        "decisionPoints": [],
        "cancerTypeStage": [
          "multi_solid_stage_II"
        ],
        "testSpecific": []
      },
      "has_decision_context": true,
      "has_direct_quotes": false,
      "has_guardrail": true
    },
    {
      "id": 252,
      "title": "Duration of adjuvant chemotherapy for stage III colon cancer",
      "source_type": "pubmed",
      "source_id": "34904905",
      "evidence_type": "meta_analysis",
      "is_superseded": false,
      "cancer_types": [
        "multi_solid"
      ],
      "clinical_settings": [],
      "questions": [],
      "classification": {
        "category": "background",
        "decisionPoints": [],
        "cancerTypeStage": [
          "multi_solid_stage_III"
        ],
        "testSpecific": []
      },
      "has_decision_context": true,
      "has_direct_quotes": false,
      "has_guardrail": true
    },
    {
      "id": 253,
      "title": "Serial circulating tumour DNA analysis during multimodality treatment of locally advanced rectal cancer: a prospective biomarker study",
      "source_type": "pubmed",
      "source_id": "29420226",
      "evidence_type": "observational",
      "is_superseded": false,
      "cancer_types": [
        "multi_solid"
      ],
      "clinical_settings": [],
      "questions": [],
      "classification": {
        "category": "background",
        "decisionPoints": [],
        "cancerTypeStage": [
          "multi_solid"
        ],
        "testSpecific": []
      },
      "has_decision_context": true,
      "has_direct_quotes": false,
      "has_guardrail": true
    },
    {
      "id": 254,
      "title": "Early detection of metastatic relapse and monitoring of therapeutic efficacy by ultra-deep sequencing of plasma cell-free DNA in patients with urothelial bladder carcinoma",
      "source_type": "pubmed",
      "source_id": "31059311",
      "evidence_type": "observational",
      "is_superseded": false,
      "cancer_types": [
        "multi_solid"
      ],
      "clinical_settings": [],
      "questions": [],
      "classification": {
        "category": "background",
        "decisionPoints": [],
        "cancerTypeStage": [
          "multi_solid"
        ],
        "testSpecific": []
      },
      "has_decision_context": true,
      "has_direct_quotes": false,
      "has_guardrail": true
    },
    {
      "id": 255,
      "title": "ALTAIR: Treatment on Molecular Recurrence (TOMR) with Trifluridine/Tipiracil in Signatera-positive Colorectal Cancer (NCT04457297)",
      "source_type": "clinicaltrials",
      "source_id": null,
      "evidence_type": "rct_results",
      "is_superseded": false,
      "cancer_types": [
        "colorectal",
        "multi_solid"
      ],
      "clinical_settings": [
        "adjuvant",
        "surveillance",
        "recurrence_detection"
      ],
      "questions": [],
      "classification": {
        "category": "background",
        "decisionPoints": [],
        "cancerTypeStage": [
          "colorectal_stage_I",
          "multi_solid_stage_I"
        ],
        "testSpecific": [
          "Signatera",
          "Natera"
        ]
      },
      "has_decision_context": false,
      "has_direct_quotes": false,
      "has_guardrail": false
    },
    {
      "id": 256,
      "title": "CIRCULATE-US: Colon Adjuvant Chemotherapy Based on Evaluation of Residual Disease",
      "source_type": "clinicaltrials",
      "source_id": "trial-NCT05174169",
      "evidence_type": "rct_ongoing",
      "is_superseded": false,
      "cancer_types": [
        "colorectal"
      ],
      "clinical_settings": [
        "adjuvant"
      ],
      "questions": [],
      "classification": {
        "category": "background",
        "decisionPoints": [],
        "cancerTypeStage": [
          "colorectal"
        ],
        "testSpecific": [
          "Signatera",
          "Natera"
        ]
      },
      "has_decision_context": false,
      "has_direct_quotes": false,
      "has_guardrail": false
    },
    {
      "id": 257,
      "title": "NCT03803553: Identification and Treatment Of Micrometastatic Disease in Stage III Colon Cancer",
      "source_type": "clinicaltrials",
      "source_id": "trial-NCT03803553",
      "evidence_type": "rct_ongoing",
      "is_superseded": false,
      "cancer_types": [
        "colorectal"
      ],
      "clinical_settings": [
        "adjuvant"
      ],
      "questions": [],
      "classification": {
        "category": "background",
        "decisionPoints": [],
        "cancerTypeStage": [
          "colorectal_stage_III"
        ],
        "testSpecific": []
      },
      "has_decision_context": false,
      "has_direct_quotes": false,
      "has_guardrail": false
    },
    {
      "id": 258,
      "title": "PLCRC: Prospective Data Collection Initiative on Colorectal Cancer",
      "source_type": "clinicaltrials",
      "source_id": "trial-NCT02070146",
      "evidence_type": "rct_ongoing",
      "is_superseded": false,
      "cancer_types": [
        "colorectal"
      ],
      "clinical_settings": [
        "adjuvant"
      ],
      "questions": [],
      "classification": {
        "category": "background",
        "decisionPoints": [],
        "cancerTypeStage": [
          "colorectal"
        ],
        "testSpecific": []
      },
      "has_decision_context": false,
      "has_direct_quotes": false,
      "has_guardrail": false
    },
    {
      "id": 259,
      "title": "CLAUDE: EO2040 in Combination With Nivolumab, for Treatment of Patients With Minimal Residual Disease of Colorectal Cancer",
      "source_type": "clinicaltrials",
      "source_id": "trial-NCT05350501",
      "evidence_type": "rct_results",
      "is_superseded": false,
      "cancer_types": [
        "colorectal"
      ],
      "clinical_settings": [
        "adjuvant"
      ],
      "questions": [],
      "classification": {
        "category": "background",
        "decisionPoints": [],
        "cancerTypeStage": [
          "colorectal_stage_II"
        ],
        "testSpecific": []
      },
      "has_decision_context": false,
      "has_direct_quotes": false,
      "has_guardrail": false
    },
    {
      "id": 260,
      "title": "NCT05060003: Tiragolumab Plus Atezolizumab Versus Atezolizumab in the Treatment of Stage II Melanoma Patients Who Are ctDNA-positive Following Resection",
      "source_type": "clinicaltrials",
      "source_id": "trial-NCT05060003",
      "evidence_type": "rct_results",
      "is_superseded": false,
      "cancer_types": [
        "melanoma"
      ],
      "clinical_settings": [
        "adjuvant"
      ],
      "questions": [],
      "classification": {
        "category": "background",
        "decisionPoints": [],
        "cancerTypeStage": [
          "melanoma_stage_II"
        ],
        "testSpecific": [
          "Signatera",
          "Natera"
        ]
      },
      "has_decision_context": false,
      "has_direct_quotes": false,
      "has_guardrail": false
    },
    {
      "id": 261,
      "title": "NCT04786600: A Phase II Randomized Therapeutic Optimization Trial for Subjects With Refractory Metastatic Colorectal Cancer Using ctDNA: Rapid 1 Trial",
      "source_type": "clinicaltrials",
      "source_id": "trial-NCT04786600",
      "evidence_type": "rct_results",
      "is_superseded": false,
      "cancer_types": [
        "colorectal"
      ],
      "clinical_settings": [
        "adjuvant"
      ],
      "questions": [],
      "classification": {
        "category": "background",
        "decisionPoints": [],
        "cancerTypeStage": [
          "colorectal"
        ],
        "testSpecific": [
          "Signatera",
          "Natera"
        ]
      },
      "has_decision_context": false,
      "has_direct_quotes": false,
      "has_guardrail": false
    },
    {
      "id": 262,
      "title": "AMPLIFY-201: A Study of ELI-002 in Subjects With KRAS Mutated Pancreatic Ductal Adenocarcinoma (PDAC) and Other Solid Tumors",
      "source_type": "clinicaltrials",
      "source_id": "trial-NCT04853017",
      "evidence_type": "rct_results",
      "is_superseded": false,
      "cancer_types": [
        "bladder",
        "colorectal",
        "lung_nsclc",
        "ovarian",
        "pancreatic"
      ],
      "clinical_settings": [
        "adjuvant"
      ],
      "questions": [],
      "classification": {
        "category": "background",
        "decisionPoints": [],
        "cancerTypeStage": [
          "bladder",
          "colorectal",
          "lung_nsclc",
          "ovarian",
          "pancreatic"
        ],
        "testSpecific": []
      },
      "has_decision_context": false,
      "has_direct_quotes": false,
      "has_guardrail": false
    },
    {
      "id": 263,
      "title": "PERSEVERE: Circulating Tumor DNA Enriched, Genomically Directed Post-neoadjuvant Trial for Patients With Residual Triple Negative Breast Cancer",
      "source_type": "clinicaltrials",
      "source_id": "trial-NCT04849364",
      "evidence_type": "rct_results",
      "is_superseded": false,
      "cancer_types": [
        "breast"
      ],
      "clinical_settings": [
        "neoadjuvant"
      ],
      "questions": [],
      "classification": {
        "category": "background",
        "decisionPoints": [],
        "cancerTypeStage": [
          "breast"
        ],
        "testSpecific": []
      },
      "has_decision_context": false,
      "has_direct_quotes": false,
      "has_guardrail": false
    },
    {
      "id": 264,
      "title": "ZEST: Efficacy and Safety Comparison of Niraparib to Placebo in Participants With Human Epidermal Growth Factor 2 Negative (HER2-) Breast Cancer Susceptibility Gene Mutation (BRCAmut) or Triple-Negative Breast Cancer (TNBC) With Molecular Disease",
      "source_type": "clinicaltrials",
      "source_id": "trial-NCT04915755",
      "evidence_type": "rct_results",
      "is_superseded": false,
      "cancer_types": [
        "breast"
      ],
      "clinical_settings": [
        "adjuvant"
      ],
      "questions": [],
      "classification": {
        "category": "background",
        "decisionPoints": [],
        "cancerTypeStage": [
          "breast"
        ],
        "testSpecific": []
      },
      "has_decision_context": false,
      "has_direct_quotes": false,
      "has_guardrail": false
    },
    {
      "id": 265,
      "title": "NCT04510285: A Single-Arm Pilot Study of Adjuvant Pembrolizumab Plus Trastuzumab in HER2+ Esophagogastric Tumors With Persistent Circulating Tumor DNA Following Curative Resection",
      "source_type": "clinicaltrials",
      "source_id": "trial-NCT04510285",
      "evidence_type": "rct_results",
      "is_superseded": false,
      "cancer_types": [
        "esophageal",
        "gastric"
      ],
      "clinical_settings": [
        "adjuvant"
      ],
      "questions": [],
      "classification": {
        "category": "background",
        "decisionPoints": [],
        "cancerTypeStage": [
          "esophageal",
          "gastric"
        ],
        "testSpecific": []
      },
      "has_decision_context": false,
      "has_direct_quotes": false,
      "has_guardrail": false
    },
    {
      "id": 266,
      "title": "ALTAIR: Initial Attack on Latent Metastasis Using TAS-102 for ct DNA Identified Colorectal Cancer Patients After Curative Resection",
      "source_type": "clinicaltrials",
      "source_id": "trial-NCT04457297",
      "evidence_type": "rct_results",
      "is_superseded": false,
      "cancer_types": [
        "colorectal"
      ],
      "clinical_settings": [
        "adjuvant"
      ],
      "questions": [],
      "classification": {
        "category": "background",
        "decisionPoints": [],
        "cancerTypeStage": [
          "colorectal"
        ],
        "testSpecific": []
      },
      "has_decision_context": false,
      "has_direct_quotes": false,
      "has_guardrail": false
    },
    {
      "id": 267,
      "title": "NCT04068103: Circulating Tumor DNA Testing in Predicting Treatment for Patients With Stage IIA Colon Cancer After Surgery",
      "source_type": "clinicaltrials",
      "source_id": "trial-NCT04068103",
      "evidence_type": "rct_results",
      "is_superseded": false,
      "cancer_types": [
        "colorectal"
      ],
      "clinical_settings": [
        "adjuvant"
      ],
      "questions": [],
      "classification": {
        "category": "background",
        "decisionPoints": [],
        "cancerTypeStage": [
          "colorectal_stage_II"
        ],
        "testSpecific": []
      },
      "has_decision_context": false,
      "has_direct_quotes": false,
      "has_guardrail": false
    },
    {
      "id": 268,
      "title": "NCT02955758: Pembrolizumab in Patients With Metastatic Non-squamous Non-small Cell Lung Cancer",
      "source_type": "clinicaltrials",
      "source_id": "trial-NCT02955758",
      "evidence_type": "rct_results",
      "is_superseded": false,
      "cancer_types": [
        "lung_nsclc"
      ],
      "clinical_settings": [
        "adjuvant"
      ],
      "questions": [],
      "classification": {
        "category": "background",
        "decisionPoints": [],
        "cancerTypeStage": [
          "lung_nsclc"
        ],
        "testSpecific": []
      },
      "has_decision_context": false,
      "has_direct_quotes": false,
      "has_guardrail": false
    },
    {
      "id": 269,
      "title": "NCT06939439: Using ctDNA to Guide Treatment Decisions for Stage III Gastric Cancer",
      "source_type": "clinicaltrials",
      "source_id": "trial-NCT06939439",
      "evidence_type": "rct_ongoing",
      "is_superseded": false,
      "cancer_types": [
        "gastric"
      ],
      "clinical_settings": [
        "adjuvant"
      ],
      "questions": [],
      "classification": {
        "category": "background",
        "decisionPoints": [],
        "cancerTypeStage": [
          "gastric_stage_III"
        ],
        "testSpecific": []
      },
      "has_decision_context": false,
      "has_direct_quotes": false,
      "has_guardrail": false
    },
    {
      "id": 270,
      "title": "TROPION-Lung12: A Phase III, Randomised Study of Adjuvant Dato-DXd in Combination With Rilvegostomig or Rilvegostomig Monotherapy Versus Standard of Care, Following Complete Tumour Resection, in Participants With Stage I Adenocarcinoma NSCLC Who Are ctDNA-positive or Have High-risk Pathological Features",
      "source_type": "clinicaltrials",
      "source_id": "trial-NCT06564844",
      "evidence_type": "rct_ongoing",
      "is_superseded": false,
      "cancer_types": [
        "lung_nsclc"
      ],
      "clinical_settings": [
        "adjuvant"
      ],
      "questions": [],
      "classification": {
        "category": "decision_support",
        "decisionPoints": [],
        "cancerTypeStage": [
          "lung_nsclc_stage_I"
        ],
        "testSpecific": []
      },
      "has_decision_context": false,
      "has_direct_quotes": false,
      "has_guardrail": false
    },
    {
      "id": 271,
      "title": "TREAT ctDNA: Elacestrant for Treating ER+/HER2- Breast Cancer Patients With ctDNA Relapse (TREAT ctDNA)",
      "source_type": "clinicaltrials",
      "source_id": "trial-NCT05512364",
      "evidence_type": "rct_ongoing",
      "is_superseded": false,
      "cancer_types": [
        "breast"
      ],
      "clinical_settings": [
        "adjuvant"
      ],
      "questions": [],
      "classification": {
        "category": "background",
        "decisionPoints": [],
        "cancerTypeStage": [
          "breast"
        ],
        "testSpecific": []
      },
      "has_decision_context": false,
      "has_direct_quotes": false,
      "has_guardrail": false
    },
    {
      "id": 272,
      "title": "NCT05954078: Circulating Tumor DNA Methylation Guided Postoperative Adjuvant Chemotherapy for High-risk Stage II/III Colorectal Cancer",
      "source_type": "clinicaltrials",
      "source_id": "trial-NCT05954078",
      "evidence_type": "rct_ongoing",
      "is_superseded": false,
      "cancer_types": [
        "colorectal"
      ],
      "clinical_settings": [
        "adjuvant"
      ],
      "questions": [],
      "classification": {
        "category": "background",
        "decisionPoints": [],
        "cancerTypeStage": [
          "colorectal_stage_II"
        ],
        "testSpecific": []
      },
      "has_decision_context": false,
      "has_direct_quotes": false,
      "has_guardrail": false
    },
    {
      "id": 273,
      "title": "NCT05797077: Postoperation Maintenance Therapy for Resectable Liver Metastases of Colorectal Cancer Guided by ctDNA",
      "source_type": "clinicaltrials",
      "source_id": "trial-NCT05797077",
      "evidence_type": "rct_ongoing",
      "is_superseded": false,
      "cancer_types": [
        "colorectal"
      ],
      "clinical_settings": [
        "adjuvant"
      ],
      "questions": [],
      "classification": {
        "category": "background",
        "decisionPoints": [],
        "cancerTypeStage": [
          "colorectal"
        ],
        "testSpecific": []
      },
      "has_decision_context": false,
      "has_direct_quotes": false,
      "has_guardrail": false
    },
    {
      "id": 274,
      "title": "CLAUDIA: Platform Study of Circulating Tumor DNA Directed Adjuvant Chemotherapy in Colon Cancer (KCSG CO22-12)",
      "source_type": "clinicaltrials",
      "source_id": "trial-NCT05534087",
      "evidence_type": "rct_ongoing",
      "is_superseded": false,
      "cancer_types": [
        "colorectal"
      ],
      "clinical_settings": [
        "adjuvant"
      ],
      "questions": [],
      "classification": {
        "category": "background",
        "decisionPoints": [],
        "cancerTypeStage": [
          "colorectal_stage_II"
        ],
        "testSpecific": []
      },
      "has_decision_context": false,
      "has_direct_quotes": false,
      "has_guardrail": false
    },
    {
      "id": 275,
      "title": "APPROACH: MRD Guiding Treatment After Almonertinib Induction Therapy for EGFRm+ Stage III NSCLC in the MDT Diagnostic Model.",
      "source_type": "clinicaltrials",
      "source_id": "trial-NCT04841811",
      "evidence_type": "rct_ongoing",
      "is_superseded": false,
      "cancer_types": [
        "lung_nsclc"
      ],
      "clinical_settings": [
        "adjuvant"
      ],
      "questions": [],
      "classification": {
        "category": "background",
        "decisionPoints": [],
        "cancerTypeStage": [
          "lung_nsclc_stage_III"
        ],
        "testSpecific": []
      },
      "has_decision_context": false,
      "has_direct_quotes": false,
      "has_guardrail": false
    },
    {
      "id": 276,
      "title": "SERENA-6: Phase III Study to Assess AZD9833+ CDK4/6 Inhibitor in HR+/HER2-MBC With Detectable ESR1m Before Progression (SERENA-6)",
      "source_type": "clinicaltrials",
      "source_id": "trial-NCT04964934",
      "evidence_type": "rct_ongoing",
      "is_superseded": false,
      "cancer_types": [
        "breast"
      ],
      "clinical_settings": [
        "adjuvant"
      ],
      "questions": [],
      "classification": {
        "category": "background",
        "decisionPoints": [],
        "cancerTypeStage": [
          "breast"
        ],
        "testSpecific": []
      },
      "has_decision_context": false,
      "has_direct_quotes": false,
      "has_guardrail": false
    },
    {
      "id": 277,
      "title": "Artemis: A Prospective, Phase II Trial Using ctDNA to Initiate Post-operation Boost Therapy After Adjuvant Chemotherapy in TNBC",
      "source_type": "clinicaltrials",
      "source_id": "trial-NCT04803539",
      "evidence_type": "rct_ongoing",
      "is_superseded": false,
      "cancer_types": [
        "breast"
      ],
      "clinical_settings": [
        "adjuvant"
      ],
      "questions": [],
      "classification": {
        "category": "background",
        "decisionPoints": [],
        "cancerTypeStage": [
          "breast"
        ],
        "testSpecific": []
      },
      "has_decision_context": false,
      "has_direct_quotes": false,
      "has_guardrail": false
    },
    {
      "id": 278,
      "title": "NCT04093167: Study of CTDNA Response Adaptive Immuno-Chemotherapy in NSCLC",
      "source_type": "clinicaltrials",
      "source_id": "trial-NCT04093167",
      "evidence_type": "rct_ongoing",
      "is_superseded": false,
      "cancer_types": [
        "lung_nsclc"
      ],
      "clinical_settings": [
        "adjuvant"
      ],
      "questions": [],
      "classification": {
        "category": "background",
        "decisionPoints": [],
        "cancerTypeStage": [
          "lung_nsclc"
        ],
        "testSpecific": []
      },
      "has_decision_context": false,
      "has_direct_quotes": false,
      "has_guardrail": false
    },
    {
      "id": 279,
      "title": "BioItaLEE: Study of the Molecular Features of Postmenopausal Women With HR+ HER2-negative aBC on First-line Treatment With Ribociclib and Letrozole and, in Patients With a PIK3CA Mutation, on Second-line Treatment With Alpelisib Plus Fulvestrant",
      "source_type": "clinicaltrials",
      "source_id": "trial-NCT03439046",
      "evidence_type": "rct_ongoing",
      "is_superseded": false,
      "cancer_types": [
        "breast"
      ],
      "clinical_settings": [
        "adjuvant"
      ],
      "questions": [],
      "classification": {
        "category": "background",
        "decisionPoints": [],
        "cancerTypeStage": [
          "breast"
        ],
        "testSpecific": []
      },
      "has_decision_context": false,
      "has_direct_quotes": false,
      "has_guardrail": false
    },
    {
      "id": 280,
      "title": "NCT01462994: Detection of CF-DNA in Patients With Gastrointestinal Stromal Tumors (GIST)",
      "source_type": "clinicaltrials",
      "source_id": "trial-NCT01462994",
      "evidence_type": "rct_ongoing",
      "is_superseded": false,
      "cancer_types": [],
      "clinical_settings": [
        "adjuvant"
      ],
      "questions": [],
      "classification": {
        "category": "background",
        "decisionPoints": [],
        "cancerTypeStage": [],
        "testSpecific": []
      },
      "has_decision_context": false,
      "has_direct_quotes": false,
      "has_guardrail": false
    },
    {
      "id": 281,
      "title": "Bridging biological cfDNA features and machine learning approaches.",
      "source_type": "pubmed",
      "source_id": "36792446",
      "evidence_type": "rct_results",
      "is_superseded": false,
      "cancer_types": [
        "multi_solid"
      ],
      "clinical_settings": [],
      "questions": [],
      "classification": {
        "category": "background",
        "decisionPoints": [],
        "cancerTypeStage": [
          "multi_solid"
        ],
        "testSpecific": []
      },
      "has_decision_context": true,
      "has_direct_quotes": false,
      "has_guardrail": false
    },
    {
      "id": 282,
      "title": "Liquid Biopsy in Solid Tumours: An Overview.",
      "source_type": "pubmed",
      "source_id": "40219616",
      "evidence_type": "rct_results",
      "is_superseded": false,
      "cancer_types": [
        "multi_solid"
      ],
      "clinical_settings": [],
      "questions": [],
      "classification": {
        "category": "background",
        "decisionPoints": [],
        "cancerTypeStage": [
          "multi_solid"
        ],
        "testSpecific": []
      },
      "has_decision_context": true,
      "has_direct_quotes": false,
      "has_guardrail": false
    },
    {
      "id": 283,
      "title": "Transitional dynamics of cancer stem cells in invasion and metastasis.",
      "source_type": "pubmed",
      "source_id": "33049522",
      "evidence_type": "rct_results",
      "is_superseded": false,
      "cancer_types": [
        "multi_solid"
      ],
      "clinical_settings": [],
      "questions": [],
      "classification": {
        "category": "background",
        "decisionPoints": [],
        "cancerTypeStage": [
          "multi_solid"
        ],
        "testSpecific": []
      },
      "has_decision_context": true,
      "has_direct_quotes": false,
      "has_guardrail": false
    },
    {
      "id": 284,
      "title": "Circulating Tumor DNA-Guided De-Escalation Targeted Therapy for Advanced Non-Small Cell Lung Cancer: A Nonrandomized Controlled Trial.",
      "source_type": "pubmed",
      "source_id": "38869865",
      "evidence_type": "rct_results",
      "is_superseded": false,
      "cancer_types": [
        "multi_solid"
      ],
      "clinical_settings": [],
      "questions": [],
      "classification": {
        "category": "background",
        "decisionPoints": [],
        "cancerTypeStage": [
          "multi_solid"
        ],
        "testSpecific": []
      },
      "has_decision_context": true,
      "has_direct_quotes": false,
      "has_guardrail": false
    },
    {
      "id": 285,
      "title": "Circulating tumor DNA in neoadjuvant-treated breast cancer reflects response and survival.",
      "source_type": "pubmed",
      "source_id": "33232761",
      "evidence_type": "rct_results",
      "is_superseded": false,
      "cancer_types": [
        "multi_solid"
      ],
      "clinical_settings": [],
      "questions": [],
      "classification": {
        "category": "background",
        "decisionPoints": [],
        "cancerTypeStage": [
          "multi_solid"
        ],
        "testSpecific": []
      },
      "has_decision_context": true,
      "has_direct_quotes": false,
      "has_guardrail": false
    },
    {
      "id": 286,
      "title": "Reporting of molecular test results from cell-free DNA analyses: expert consensus recommendations from the 2023 European Liquid Biopsy Society ctDNA Workshop.",
      "source_type": "pubmed",
      "source_id": "40121940",
      "evidence_type": "rct_results",
      "is_superseded": false,
      "cancer_types": [
        "multi_solid"
      ],
      "clinical_settings": [],
      "questions": [],
      "classification": {
        "category": "decision_support",
        "decisionPoints": [],
        "cancerTypeStage": [
          "multi_solid"
        ],
        "testSpecific": []
      },
      "has_decision_context": true,
      "has_direct_quotes": false,
      "has_guardrail": false
    }
  ]
}